Enhanced	O
responsiveness	O
to	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
contributes	O
to	O
the	O
unique	O
phenotype	O
of	O
simian	O
immunodeficiency	O
virus	O
variant	O
SIVsmmPBj14	O
.	O

Infection	O
with	O
a	O
variant	O
of	O
simian	O
immunodeficiency	O
virus	O
,	O
SIVsmmPBj14	O
,	O
leads	O
to	O
severe	O
acute	O
disease	O
in	O
macaques	O
.	O

This	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
functional	O
significance	O
of	O
previously	O
described	O
mutations	O
in	O
the	O
viral	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
and	O
to	O
elucidate	O
their	O
contribution	O
to	O
the	O
unique	O
phenotype	O
of	O
SIVsmmPBj14	O
.	O

LTR	B-DNA
-directed	O
transcription	O
was	O
measured	O
by	O
using	O
luciferase	B-DNA
reporter	I-DNA
constructs	I-DNA
that	O
were	O
transiently	O
transfected	O
into	O
cultured	B-cell_line
cells	I-cell_line
.	O

In	O
a	O
wide	O
range	O
of	O
cell	O
types	O
,	O
the	O
basal	O
transcriptional	O
activity	O
of	O
the	O
LTR	B-DNA
from	O
SIVsmmPBj14	O
was	O
found	O
to	O
be	O
2-	O
to	O
4.5-fold	O
higher	O
than	O
that	O
of	O
an	O
LTR	B-DNA
from	O
a	O
non-acutely	O
pathogenic	O
strain	O
.	O

These	O
LTRs	B-DNA
differ	O
by	O
five	O
point	O
mutations	O
and	O
a	O
22-bp	B-DNA
duplication	I-DNA
in	O
SIVsmmPBj14	O
,	O
which	O
includes	O
a	O
nuclear	B-DNA
factor	I-DNA
kappa	I-DNA
B	I-DNA
(	I-DNA
NF	I-DNA
kappa	I-DNA
B	I-DNA
)	I-DNA
site	I-DNA
.	O

Transcriptional	O
differences	O
between	O
these	O
LTRs	B-DNA
were	O
further	O
enhanced	O
by	O
two-	O
to	O
threefold	O
upon	O
treatment	O
of	O
cells	O
with	O
phorbol	O
ester	O
or	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
or	O
by	O
cotransfection	O
with	O
plasmids	B-DNA
expressing	O
NF	B-protein
kappa	I-protein
B	I-protein
subunits	O
.	O

Mutagenesis	O
studies	O
,	O
and	O
the	O
use	O
of	O
a	O
reporter	O
construct	O
containing	O
an	O
enhancerless	O
promoter	O
,	O
indicate	O
that	O
these	O
transcriptional	O
effects	O
are	O
due	O
principally	O
to	O
the	O
22-bp	B-DNA
sequence	I-DNA
duplication	I-DNA
and	O
the	O
NF	B-DNA
kappa	I-DNA
B	I-DNA
site	I-DNA
contained	O
within	O
it	O
.	O

Finally	O
,	O
infectious	O
virus	O
stocks	O
that	O
were	O
isogenic	O
except	O
for	O
the	O
LTR	B-DNA
were	O
generated	O
.	O

The	O
LTR	B-DNA
from	O
SIVsmmPBj14	O
was	O
found	O
to	O
confer	O
an	O
increase	O
in	O
the	O
kinetics	O
of	O
virus	O
replication	O
in	O
cultured	B-cell_line
cells	I-cell_line
.	O

Inclusion	O
of	O
this	O
LTR	B-DNA
in	O
recombinant	O
SIVs	O
also	O
resulted	O
in	O
a	O
two-	O
to	O
threefold	O
rise	O
in	O
the	O
extent	O
of	O
cellular	O
proliferation	O
that	O
was	O
induced	O
in	O
quiescent	B-cell_line
simian	I-cell_line
peripheral	I-cell_line
blood	I-cell_line
mononuclear	I-cell_line
cells	I-cell_line
.	O

These	O
studies	O
are	O
consistent	O
with	O
the	O
hypothesis	O
that	O
LTR	B-DNA
mutations	O
assist	O
SIVsmmPBj14	O
in	O
responding	O
efficiently	O
to	O
cellular	O
stimulation	O
and	O
allow	O
it	O
to	O
replicate	O
to	O
high	O
titers	O
during	O
the	O
acute	O
phase	O
of	O
viral	O
infection	O
.	O

JournNAL	NULL
or	NULL
ViroLOGY	NULL
,	NULL
Dec.	NULL
1994	NULL
,	NULL
p.	NULL
7800-7809	NULL
0022-538	NULL
X/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

68	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Enhanced	NULL
Responsiveness	NULL
to	NULL
Nuclear	NULL
Factor	NULL
kB	NULL
Contributes	NULL
to	NULL
the	NULL
Unique	NULL
Phenotype	NULL
of	NULL
Simian	NULL
Immunodeficiency	NULL
Virus	NULL
Variant	NULL
SIV	NULL
gnmpBj14	NULL
SHEILA	NULL
C.	NULL
DOLLARD	NULL
,	NULL
'	NULL
SURYARAM	NULL
GUMMULURU	NULL
,	NULL
'	NULL
SOLAM	NULL
TSANG	NULL
,	NULL
'	NULL
PATRICIA	NULL
N.	NULL
FULTZ	NULL
,	NULL
anp	NULL
STEPHEN	NULL
DEWHURST'**	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Rochester	NULL
Medical	NULL
Center	NULL
,	NULL
``	NULL
and	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Rochester	NULL
,	NULL
``	NULL
Rochester	NULL
,	NULL
New	NULL
York	NULL
14642	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
University	NULL
of	NULL
Alabama	NULL
at	NULL
Birmingham	NULL
,	NULL
Birmingham	NULL
,	NULL
Alabama	NULL
35294	NULL
Received	NULL
25	NULL
May	NULL
1994/Accepted	NULL
31	NULL
August	NULL
1994	NULL
Infection	NULL
with	NULL
a	NULL
variant	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
,	NULL
leads	NULL
to	NULL
severe	NULL
acute	NULL
disease	NULL
in	NULL
macaques	NULL
.	NULL

This	NULL
study	NULL
was	NULL
designed	NULL
to	NULL
investigate	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
previously	NULL
described	NULL
mutations	NULL
in	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
and	NULL
to	NULL
elucidate	NULL
their	NULL
contribution	NULL
to	NULL
the	NULL
unique	NULL
phenotype	NULL
of	NULL
LTR-directed	NULL
transcription	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
that	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
cultured	NULL
cells	NULL
.	NULL

In	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
the	NULL
basal	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
from	NULL
SIV	NULL
was	NULL
found	NULL
to	NULL
be	NULL
2-	NULL
to	NULL
4.5-fold	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
an	NULL
LTR	NULL
from	NULL
a	NULL
non-acutely	NULL
pathogenic	NULL
strain	NULL
.	NULL

These	NULL
LTRs	NULL
differ	NULL
by	NULL
five	NULL
point	NULL
mutations	NULL
and	NULL
a	NULL
22-bp	NULL
duplication	NULL
in	NULL
SIV	NULL
...	NULL
upg	NULL
;	NULL
14	NULL
,	NULL
Which	NULL
includes	NULL
a	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NFB	NULL
)	NULL
site	NULL
.	NULL

Transcriptional	NULL
differences	NULL
between	NULL
these	NULL
LTRs	NULL
were	NULL
further	NULL
enhanced	NULL
by	NULL
two-to	NULL
threefold	NULL
upon	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
or	NULL
by	NULL
cotransfection	NULL
with	NULL
plasmids	NULL
expressing	NULL
NFB	NULL
subunits	NULL
.	NULL

Mutagenesis	NULL
studies	NULL
,	NULL
and	NULL
the	NULL
use	NULL
of	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
an	NULL
enhancerless	NULL
promoter	NULL
,	NULL
indicate	NULL
that	NULL
these	NULL
transcriptional	NULL
effects	NULL
are	NULL
due	NULL
principally	NULL
to	NULL
the	NULL
22-bp	NULL
sequence	NULL
duplication	NULL
and	NULL
the	NULL
NFB	NULL
site	NULL
contained	NULL
within	NULL
it	NULL
.	NULL

Finally	NULL
,	NULL
infectious	NULL
virus	NULL
stocks	NULL
that	NULL
were	NULL
isogenic	NULL
except	NULL
for	NULL
the	NULL
LTR	NULL
were	NULL
generated	NULL
.	NULL

The	NULL
LTR	NULL
from	NULL
SIV	NULL
...	NULL
upg	NULL
;	NULL
,	NULL
,	NULL
was	NULL
found	NULL
to	NULL
confer	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
kinetics	NULL
of	NULL
virus	NULL
replication	NULL
in	NULL
cultured	NULL
cells	NULL
.	NULL

Inclusion	NULL
of	NULL
this	NULL
LTR	NULL
in	NULL
recombinant	NULL
SIVs	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
two-	NULL
to	NULL
threefold	NULL
rise	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
cellular	NULL
proliferation	NULL
that	NULL
was	NULL
induced	NULL
in	NULL
quiescent	NULL
simian	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

These	NULL
studies	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
LTR	NULL
mutations	NULL
assist	NULL
in	NULL
responding	NULL
efficiently	NULL
to	NULL
cellular	NULL
stimulation	NULL
and	NULL
allow	NULL
it	NULL
to	NULL
replicate	NULL
to	NULL
high	NULL
titers	NULL
during	NULL
the	NULL
acute	NULL
phase	NULL
of	NULL
viral	NULL
infection	NULL
.	NULL

Simian	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
SIV	NULL
)	NULL
infection	NULL
in	NULL
experimentally	NULL
inoculated	NULL
rhesus	NULL
macaques	NULL
typically	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
AIDS-like	NULL
disease	NULL
characterized	NULL
by	NULL
wasting	NULL
,	NULL
diarrhea	NULL
,	NULL
thymic	NULL
atrophy	NULL
,	NULL
depletion	NULL
of	NULL
CD4*	NULL
lymphocytes	NULL
,	NULL
opportunistic	NULL
infections	NULL
,	NULL
central	NULL
nervous	NULL
system	NULL
degeneration	NULL
,	NULL
and	NULL
death	NULL
within	NULL
5	NULL
to	NULL
18	NULL
months	NULL
(	NULL
39	NULL
,	NULL
45	NULL
)	NULL
.	NULL

These	NULL
properties	NULL
,	NULL
together	NULL
with	NULL
the	NULL
close	NULL
genetic	NULL
similarity	NULL
between	NULL
SIV	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
types	NULL
1	NULL
and	NULL
2	NULL
(	NULL
HIV-1	NULL
and	NULL
HIV-2	NULL
)	NULL
,	NULL
make	NULL
the	NULL
SIV/macaque	NULL
model	NULL
ideal	NULL
for	NULL
the	NULL
study	NULL
of	NULL
AIDS	NULL
pathogenesis	NULL
.	NULL

The	NULL
disease	NULL
induced	NULL
by	NULL
HIV-1	NULL
and	NULL
SIV	NULL
is	NULL
slow	NULL
and	NULL
progres-sive	NULL
,	NULL
and	NULL
it	NULL
is	NULL
preceded	NULL
by	NULL
an	NULL
acute	NULL
viral	NULL
syndrome	NULL
that	NULL
occurs	NULL
within	NULL
the	NULL
first	NULL
2	NULL
weeks	NULL
of	NULL
infection	NULL
,	NULL
prior	NULL
to	NULL
seroconversion	NULL
.	NULL

Acute-phase	NULL
HIV-1	NULL
disease	NULL
is	NULL
marked	NULL
by	NULL
a	NULL
peak	NULL
of	NULL
antigenemia	NULL
,	NULL
viremia	NULL
,	NULL
and	NULL
widespread	NULL
viral	NULL
dissemination	NULL
throughout	NULL
the	NULL
lymphoid	NULL
organs	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

The	NULL
clinical	NULL
presentation	NULL
includes	NULL
flu-like	NULL
symptoms	NULL
,	NULL
diarrhea	NULL
,	NULL
lymphadenopathy	NULL
,	NULL
rash	NULL
,	NULL
fever	NULL
,	NULL
and	NULL
malaise	NULL
(	NULL
11	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
long	NULL
asymptomatic	NULL
period	NULL
in	NULL
which	NULL
virus	NULL
replication	NULL
continues	NULL
in	NULL
the	NULL
lymphoid	NULL
sites	NULL
that	NULL
were	NULL
presumably	NULL
seeded	NULL
during	NULL
the	NULL
acute	NULL
syndrome	NULL
(	NULL
21	NULL
,	NULL
51	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
SIV	NULL
,	NULL
less	NULL
is	NULL
known	NULL
concerning	NULL
the	NULL
acute	NULL
phase	NULL
of	NULL
infection	NULL
;	NULL
however	NULL
within	NULL
the	NULL
first	NULL
2	NULL
weeks	NULL
of	NULL
infection	NULL
,	NULL
SIV-infected	NULL
macaques	NULL
develop	NULL
many	NULL
of	NULL
the	NULL
same	NULL
symp-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Rochester	NULL
Medical	NULL
Center	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
14642	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
716	NULL
)	NULL
275-3216	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
716	NULL
)	NULL
473-9573	NULL
.	NULL

Electronicmailaddress	NULL
:	NULL
DWRT	NULL
@	NULL
BPHVAX.BIOPHYSICS.ROCHES-TER.EDU	NULL
.	NULL

7800	NULL
toms	NULL
as	NULL
HIV-1-infected	NULL
humans	NULL
,	NULL
including	NULL
antigenemia	NULL
,	NULL
rash	NULL
,	NULL
and	NULL
lymphadenopathy	NULL
(	NULL
39	NULL
,	NULL
45	NULL
,	NULL
54	NULL
)	NULL
.	NULL

One	NULL
strain	NULL
of	NULL
SIV	NULL
,	NULL
SIV	NULL
;	NULL
,	NULL
,	NULL
,	NULL
pp	NULL
;	NULL
14	NULL
,	NULL
induces	NULL
an	NULL
especially	NULL
severe	NULL
acute-phase	NULL
infection	NULL
in	NULL
experimentally	NULL
inoculated	NULL
pig-tailed	NULL
macaques	NULL
(	NULL
Macaca	NULL
nemestrina	NULL
)	NULL
.	NULL

This	NULL
syndrome	NULL
is	NULL
marked	NULL
by	NULL
very	NULL
severe	NULL
gastrointestinal	NULL
symptoms	NULL
and	NULL
diarrhea	NULL
and	NULL
by	NULL
death	NULL
in	NULL
most	NULL
cases	NULL
between	NULL
7	NULL
and	NULL
10	NULL
days	NULL
postinoculation	NULL
(	NULL
25	NULL
,	NULL
32	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Gut-associated	NULL
lymphoid	NULL
areas	NULL
are	NULL
heavily	NULL
involved	NULL
in	NULL
the	NULL
disease	NULL
pathogenesis	NULL
,	NULL
and	NULL
there	NULL
is	NULL
a	NULL
profound	NULL
local	NULL
inflammatory	NULL
reaction	NULL
,	NULL
marked	NULL
by	NULL
lymphoid	NULL
hyperplasia	NULL
,	NULL
tissue	NULL
dam-age	NULL
,	NULL
and	NULL
high	NULL
serum	NULL
levels	NULL
of	NULL
certain	NULL
cytokines	NULL
,	NULL
including	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
(	NULL
8	NULL
,	NULL
59	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
may	NULL
be	NULL
related	NULL
to	NULL
SIV	NULL
;	NULL
,	NULL
.pg	NULL
;	NULL
14	NULL
's	NULL
unique	NULL
ability	NULL
,	NULL
among	NULL
primate	NULL
lentiviruses	NULL
,	NULL
to	NULL
trigger	NULL
proliferation	NULL
of	NULL
resting	NULL
simian	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
in	NULL
vitro	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Biologic	NULL
virus	NULL
clones	NULL
were	NULL
derived	NULL
from	NULL
DY	NULL
limiting-dilution	NULL
cloning	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
derivation	NULL
of	NULL
stocks	NULL
with	NULL
both	NULL
acutely	NULL
pathogenic	NULL
(	NULL
AP	NULL
)	NULL
(	NULL
bel-3	NULL
)	NULL
and	NULL
non-acutely	NULL
pathogenic	NULL
(	NULL
NAP	NULL
)	NULL
(	NULL
bel-1	NULL
)	NULL
phenotypes	NULL
(	NULL
25	NULL
)	NULL
.	NULL

SIV	NULL
sequences	NULL
from	NULL
these	NULL
stocks	NULL
were	NULL
subsequently	NULL
cloned	NULL
by	NULL
PCR	NULL
amplifi-cation	NULL
,	NULL
sequenced	NULL
,	NULL
and	NULL
tested	NULL
in	NULL
vivo	NULL
(	NULL
16	NULL
)	NULL
.	NULL

An	NULL
AP	NULL
molecular	NULL
clone	NULL
of	NULL
designated	NULL
PBj-1.9	NULL
,	NULL
was	NULL
derived	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
sequence	NULL
analysis	NULL
identified	NULL
a	NULL
total	NULL
of	NULL
fewer	NULL
than	NULL
100	NULL
mutational	NULL
changes	NULL
(	NULL
99	NULL
%	NULL
sequence	NULL
identity	NULL
)	NULL
between	NULL
this	NULL
clone	NULL
and	NULL
the	NULL
NAP	NULL
bel-1	NULL
virus	NULL
stock	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
changes	NULL
map	NULL
to	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
.	NULL

Most	NULL
notably	NULL
,	NULL
bel-3	NULL
contains	NULL
a	NULL
tandem	NULL
22-bp	NULL
duplication	NULL
that	NULL
contains	NULL
a	NULL
nuclear	NULL
factor	NULL
kB	NULL
(	NULL
NFB	NULL
)	NULL
site	NULL
(	NULL
five	NULL
of	NULL
five	NULL
clones	NULL
)	NULL
,	NULL
whereas	NULL
bel-1	NULL
does	NULL
not	NULL
(	NULL
eight	NULL
of	NULL
eight	NULL
clones	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
In	NULL
the	NULL
case	NULL
Of	NULL
SIV	NULL
smmppji4	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
several	NULL
viral	NULL
determinants	NULL
,	NULL
most	NULL
notably	NULL
the	NULL
env	NULL
gene	NULL
,	NULL
contribute	NULL
to	NULL
acute	NULL
disease	NULL
induction	NULL
(	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
LTR	NULL
mutations	NULL
in	NULL
SIV	NULL
inmpp	NULL
;	NULL
i	NULL
,	NULL
remains	NULL
uncertain	NULL
,	NULL
although	NULL
several	NULL
facts	NULL
suggest	NULL
that	NULL
they	NULL
may	NULL
be	NULL
important	NULL
.	NULL

First	NULL
,	NULL
these	NULL
LTR	NULL
changes	NULL
are	NULL
highly	NULL
conserved	NULL
among	NULL
acutely	NULL
pathogenic	NULL
clones	NULL
of	NULL
SIV	NULL
mmppji4a	NULL
(	NULL
12	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
there	NULL
is	NULL
precedent	NULL
for	NULL
similar	NULL
mutations	NULL
being	NULL
important	NULL
determinants	NULL
of	NULL
pathogenesis	NULL
in	NULL
other	NULL
retroviruses	NULL
(	NULL
23	NULL
,	NULL
31	NULL
,	NULL
37	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
many	NULL
of	NULL
the	NULL
cytokines	NULL
induced	NULL
during	NULL
HIV-1	NULL
or	NULL
SIV	NULL
infection	NULL
,	NULL
including	NULL
IL-6	NULL
and	NULL
TNF-	NULL
«	NULL
,	NULL
are	NULL
known	NULL
to	NULL
activate	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
NFB	NULL
(	NULL
4	NULL
,	NULL
8	NULL
,	NULL
9	NULL
,	NULL
20	NULL
,	NULL
33	NULL
,	NULL
42	NULL
,	NULL
50	NULL
,	NULL
53	NULL
,	NULL
59	NULL
)	NULL
.	NULL

This	NULL
interplay	NULL
between	NULL
cytokines	NULL
and	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
particularly	NULL
pertinent	NULL
to	NULL
in	NULL
light	NULL
of	NULL
the	NULL
duplicated	NULL
NFB	NULL
site	NULL
in	NULL
the	NULL
LTR	NULL
enhancer	NULL
region	NULL
of	NULL
this	NULL
virus	NULL
(	NULL
16	NULL
)	NULL
.	NULL

This	NULL
study	NULL
,	NULL
therefore	NULL
,	NULL
evaluates	NULL
the	NULL
contribution	NULL
of	NULL
LTR	NULL
changes	NULL
to	NULL
the	NULL
unique	NULL
phenotype	NULL
Of	NULL
SIV	NULL
.nnpg	NULL
;	NULL
i4	NULL
.	NULL

Two	NULL
complementary	NULL
assay	NULL
systems	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
these	NULL
LTR	NULL
mutations	NULL
.	NULL

First	NULL
,	NULL
transient	NULL
transcriptional	NULL
studies	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
and	NULL
primary	NULL
cells	NULL
,	NULL
using	NULL
LTR-luciferase	NULL
reporter	NULL
plasmids	NULL
.	NULL

These	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
agents	NULL
known	NULL
to	NULL
stimulate	NULL
NFB	NULL
,	NULL
including	NULL
TNF-	NULL
«	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
constructed	NULL
infectious	NULL
SIVs	NULL
in	NULL
which	NULL
LTR	NULL
elements	NULL
were	NULL
exchanged	NULL
between	NULL
otherwise	NULL
isogenic	NULL
viruses	NULL
.	NULL

Infection	NULL
experiments	NULL
using	NULL
these	NULL
viral	NULL
stocks	NULL
allowed	NULL
us	NULL
to	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
LTR	NULL
mutations	NULL
on	NULL
viral	NULL
properties	NULL
,	NULL
including	NULL
replication	NULL
kinetics	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
virus	NULL
to	NULL
trigger	NULL
proliferation	NULL
of	NULL
resting	NULL
PBMC	NULL
from	NULL
pig-tailed	NULL
macaques	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
show	NULL
that	NULL
sequence	NULL
mutations	NULL
in	NULL
the	NULL
SIV	NULL
gnmppii4	NULL
LTR	NULL
result	NULL
in	NULL
elevated	NULL
levels	NULL
of	NULL
transcription	NULL
and	NULL
faster	NULL
kinetics	NULL
of	NULL
viral	NULL
replication	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
data	NULL
indicate	NULL
that	NULL
these	NULL
differences	NULL
are	NULL
due	NULL
primarily	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
additional	NULL
NFKB	NULL
site	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Maintenance	NULL
of	NULL
cells	NULL
.	NULL

Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
research	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
or	NULL
the	NULL
NIH/NIAID	NULL
AIDS	NULL
Reagent	NULL
Repository	NULL
and	NULL
were	NULL
maintained	NULL
under	NULL
conditions	NULL
recommended	NULL
by	NULL
the	NULL
supplier	NULL
.	NULL

Human	NULL
cell	NULL
lines	NULL
included	NULL
SW480	NULL
(	NULL
colon	NULL
carcinoma	NULL
)	NULL
,	NULL
U-87MG	NULL
(	NULL
astrocytoma	NULL
)	NULL
,	NULL
U-138MG	NULL
(	NULL
astrocytoma	NULL
)	NULL
,	NULL
J-Jahn	NULL
(	NULL
CD4*	NULL
T	NULL
cell	NULL
)	NULL
,	NULL
Jurkat	NULL
(	NULL
CD4*	NULL
T	NULL
cell	NULL
)	NULL
,	NULL
CEM	NULL
174	NULL
(	NULL
CD4*	NULL
B-cell/T-cell	NULL
hybrid	NULL
)	NULL
,	NULL
and	NULL
U937	NULL
(	NULL
monocytic	NULL
)	NULL
.	NULL

Simian	NULL
cell	NULL
lines	NULL
were	NULL
ChM114	NULL
(	NULL
simian	NULL
T-cell	NULL
leukemia	NULL
virus-transformed	NULL
chimpanzee	NULL
T	NULL
cells	NULL
)	NULL
and	NULL
Si-IIA	NULL
(	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
[	NULL
HTLV-lIJ-transformed	NULL
cynomolgus	NULL
macaque	NULL
T	NULL
cells	NULL
)	NULL
and	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
46	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Primary	NULL
human	NULL
PBMC	NULL
were	NULL
isolated	NULL
from	NULL
human	NULL
blood	NULL
by	NULL
using	NULL
Ficoll-Paque	NULL
as	NULL
instructed	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
5	NULL
%	NULL
IL-2	NULL
,	NULL
and	NULL
1	NULL
%	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
prior	NULL
to	NULL
electroporation	NULL
and	NULL
without	NULL
PHA	NULL
after	NULL
electropora-tion	NULL
.	NULL

Plasmid	NULL
construction	NULL
.	NULL

Full-length	NULL
LTR-luciferase	NULL
plasmids	NULL
were	NULL
generated	NULL
as	NULL
follows	NULL
.	NULL

PCR	NULL
amplification	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
intact	NULL
LTR	NULL
elements	NULL
from	NULL
full-length	NULL
SIV	NULL
genomic	NULL
clones	NULL
PBj-1.9	NULL
(	NULL
AP	NULL
)	NULL
and	NULL
PBj-1.b	NULL
(	NULL
NAP	NULL
)	NULL
.	NULL

LTR	NULL
sequences	NULL
from	NULL
~560	NULL
to	NULL
+321	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
luciferase	NULL
expression	NULL
vector	NULL
pXP1	NULL
(	NULL
48	NULL
)	NULL
as	NULL
a	NULL
HindlIII-to-Smal	NULL
cassette	NULL
and	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Truncated	NULL
LTR-luciferase	NULL
plasmids	NULL
were	NULL
then	NULL
made	NULL
by	NULL
digesting	NULL
the	NULL
full-length	NULL
clones	NULL
with	NULL
HindIII	NULL
and	NULL
StuI	NULL
to	NULL
remove	NULL
LTR	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
Stul	NULL
site	NULL
at	NULL
nucleotide	NULL
-172	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
mutated	NULL
derivative	NULL
of	NULL
the	NULL
trun-	NULL
CONTRIBUTION	NULL
OF	NULL
NFkB	NULL
TO	NULL
PHENOTYPE	NULL
OF	NULL
$	NULL
IVannmesia	NULL
-_	NULL
7801	NULL
cated	NULL
NAP	NULL
LTR-luciferase	NULL
construct	NULL
was	NULL
also	NULL
generated	NULL
,	NULL
in	NULL
which	NULL
a	NULL
second	NULL
copy	NULL
of	NULL
the	NULL
previously	NULL
identified	NULL
22-bp	NULL
LTR	NULL
enhancer	NULL
element	NULL
in	NULL
SIV	NULL
was	NULL
inserted	NULL
by	NULL
PCR	NULL
mutagenesis	NULL
(	NULL
30	NULL
)	NULL
using	NULL
Pfu	NULL
DNA	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
)	NULL
;	NULL
this	NULL
clone	NULL
is	NULL
designated	NULL
NAP-M	NULL
.	NULL

The	NULL
same	NULL
22-bp	NULL
element	NULL
was	NULL
also	NULL
synthesized	NULL
as	NULL
an	NULL
oligonucleotide	NULL
,	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
either	NULL
the	NULL
wild-type	NULL
or	NULL
the	NULL
NFB	NULL
mutant	NULL
sequence	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Smal	NULL
and	NULL
Xhol	NULL
sites	NULL
of	NULL
pSluc2	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
luciferase	NULL
gene	NULL
and	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
enhancerless	NULL
promoter	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Clones	NULL
pWR1	NULL
and	NULL
pWR2	NULL
contain	NULL
one	NULL
and	NULL
two	NULL
copies	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
the	NULL
wild-type	NULL
22-bp	NULL
element	NULL
.	NULL

In	NULL
clones	NULL
pMR1	NULL
and	NULL
pMR2	NULL
,	NULL
the	NULL
GGG	NULL
motif	NULL
in	NULL
the	NULL
NFkB	NULL
site	NULL
was	NULL
altered	NULL
to	NULL
the	NULL
nonfunctional	NULL
triplet	NULL
motif	NULL
,	NULL
CTC	NULL
(	NULL
47	NULL
)	NULL
.	NULL

These	NULL
clones	NULL
thus	NULL
contain	NULL
one	NULL
and	NULL
two	NULL
copies	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
an	NULL
NFkB	NULL
mutant	NULL
and	NULL
a	NULL
wild-type	NULL
simian	NULL
factor	NULL
3	NULL
(	NULL
SF3	NULL
)	NULL
sequence	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

For	NULL
Tat	NULL
expression	NULL
vectors	NULL
,	NULL
the	NULL
SIV	NULL
insert	NULL
in	NULL
clone	NULL
pST	NULL
(	NULL
64	NULL
)	NULL
was	NULL
replaced	NULL
with	NULL
tat	NULL
coding	NULL
sequences	NULL
(	NULL
bases	NULL
6015	NULL
to	NULL
8699	NULL
)	NULL
from	NULL
either	NULL
clone	NULL
PBj-3'-9	NULL
or	NULL
clone	NULL
PBj-3'-b	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
to	NULL
generate	NULL
clones	NULL
capable	NULL
of	NULL
expressing	NULL
AP-	NULL
or	NULL
NAP-Tat	NULL
protein	NULL
,	NULL
respectively	NULL
.	NULL

Transient	NULL
expression	NULL
assays	NULL
.	NULL

SW480	NULL
,	NULL
U-87MG	NULL
,	NULL
and	NULL
U-138	NULL
MG	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
low-CO	NULL
,	NULL
method	NULL
of	NULL
Chen	NULL
and	NULL
Okayama	NULL
(	NULL
13	NULL
)	NULL
in	NULL
60-mm-diameter	NULL
plates	NULL
,	NULL
using	NULL
3	NULL
to	NULL
6	NULL
pug	NULL
of	NULL
total	NULL
DNA	NULL
per	NULL
plate	NULL
.	NULL

J-Jahn	NULL
,	NULL
Jurkat	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
Si-IIA	NULL
cell	NULL
lines	NULL
were	NULL
electroporated	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
mM	NULL
dextrose	NULL
and	NULL
0.1	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
5	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
,	NULL
using	NULL
15	NULL
ug	NULL
of	NULL
total	NULL
DNA	NULL
in	NULL
0.4-cm	NULL
gap	NULL
cuvettes	NULL
at	NULL
960	NULL
F	NULL
and	NULL
300	NULL
V.	NULL
ChM114	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
,	NULL
using	NULL
10	NULL
cells	NULL
and	NULL
6	NULL
ug	NULL
of	NULL
total	NULL
DNA	NULL
(	NULL
1	NULL
)	NULL
.	NULL

PBMC	NULL
were	NULL
electroporated	NULL
in	NULL
cytomix	NULL
buffer	NULL
under	NULL
the	NULL
conditions	NULL
used	NULL
for	NULL
J-Jahn	NULL
cells	NULL
(	NULL
63	NULL
)	NULL
.	NULL

Where	NULL
noted	NULL
,	NULL
1,3-phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
;	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
20	NULL
ng/ml	NULL
at	NULL
14	NULL
h	NULL
posttransfection	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
6	NULL
h	NULL
thereafter	NULL
.	NULL

TNF-	NULL
«	NULL
(	NULL
Genzyme	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
ng/ml	NULL
at	NULL
14	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
24	NULL
h	NULL
later	NULL
.	NULL

In	NULL
experiments	NULL
in	NULL
which	NULL
NFB	NULL
expression	NULL
vectors	NULL
were	NULL
used	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
8	NULL
pg	NULL
of	NULL
LTR-luciferase	NULL
plasmid	NULL
plus	NULL
4	NULL
pg	NULL
of	NULL
each	NULL
NFKB	NULL
plasmid	NULL
or	NULL
8	NULL
mg	NULL
of	NULL
pUC19	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
and	NULL
harvested	NULL
for	NULL
luciferase	NULL
assays	NULL
42	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

In	NULL
experiments	NULL
in	NULL
which	NULL
Tat	NULL
expression	NULL
vectors	NULL
were	NULL
used	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
mg	NULL
of	NULL
LTR-luciferase	NULL
plasmid	NULL
plus	NULL
10	NULL
g	NULL
of	NULL
SIV	NULL
Tat	NULL
plasmid	NULL
or	NULL
10	NULL
ug	NULL
of	NULL
pUC19	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
and	NULL
harvested	NULL
for	NULL
luciferase	NULL
assays	NULL
36	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
assayed	NULL
by	NULL
using	NULL
commercially	NULL
available	NULL
reagents	NULL
(	NULL
Pro-mega	NULL
)	NULL
in	NULL
an	NULL
LKB	NULL
series	NULL
1250	NULL
luminometer	NULL
.	NULL

Values	NULL
presented	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
(	NULL
see	NULL
figure	NULL
legends	NULL
)	NULL
;	NULL
variability	NULL
between	NULL
experimental	NULL
duplicates	NULL
was	NULL
typically	NULL
<	NULL
15	NULL
%	NULL
.	NULL

Protein-DNA	NULL
binding	NULL
analysis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Lee	NULL
and	NULL
colleagues	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
3	NULL
%	NULL
10	NULL
``	NULL
to	NULL
5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
allowed	NULL
to	NULL
swell	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
then	NULL
lysed	NULL
rapidly	NULL
by	NULL
passage	NULL
through	NULL
a	NULL
hypodermic	NULL
heedle	NULL
.	NULL

The	NULL
nuclear	NULL
component	NULL
was	NULL
lysed	NULL
,	NULL
dialyzed	NULL
against	NULL
low-salt	NULL
buffer	NULL
,	NULL
snap	NULL
frozen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

The	NULL
final	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
extracts	NULL
was	NULL
generally	NULL
5	NULL
to	NULL
10	NULL
mg/ml	NULL
.	NULL

Binding	NULL
activity	NULL
was	NULL
detected	NULL
by	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
(	NULL
22	NULL
,	NULL
26	NULL
)	NULL
,	NULL
in	NULL
which	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
mixed	NULL
with	NULL
10,000	NULL
cpm	NULL
of	NULL
*°P-end-labeled	NULL
DNA	NULL
,	NULL
with	NULL
or	NULL
without	NULL
competitor	NULL
DNA	NULL
,	NULL
at	NULL
30°C	NULL
for	NULL
20	NULL
min	NULL
and	NULL
electropho-resed	NULL
through	NULL
a	NULL
4	NULL
%	NULL
Tris-borate	NULL
gel	NULL
.	NULL

Full-length	NULL
viral	NULL
recombinants	NULL
.	NULL

LTR	NULL
recombinant	NULL
virus	NULL
stocks	NULL
were	NULL
generated	NULL
by	NULL
using	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
SIV	NULL
half-genome	NULL
clones	NULL
as	NULL
follows	NULL
.	NULL

For	NULL
each	NULL
recombinant	NULL
constructed	NULL
,	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
LTR	NULL
elements	NULL
were	NULL
identical	NULL
,	NULL
thereby	NULL
precluding	NULL
7802	NULL
DOLLARD	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
PuBi1	NULL
PuB2	NULL
xB	NULL
SF3	NULL
«	NULL
B	NULL
SF3	NULL
-	NULL
Spi	NULL
J.	NULL
ViroL	NULL
.	NULL

NFxB/SF3	NULL
MFxB/SF3	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
LTR	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
positions	NULL
of	NULL
known	NULL
or	NULL
putative	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
and	NULL
of	NULL
the	NULL
transactivation	NULL
responsive	NULL
element	NULL
(	NULL
TAR	NULL
)	NULL
are	NULL
marked	NULL
.	NULL

Motifs	NULL
indicated	NULL
include	NULL
putative	NULL
purine	NULL
box	NULL
elements	NULL
(	NULL
PuB1	NULL
and	NULL
PuB2	NULL
;	NULL
consensus	NULL
motif	NULL
;	NULL
AGGAA	NULL
)	NULL
,	NULL
NFB	NULL
,	NULL
SF3	NULL
,	NULL
and	NULL
Sp1	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
position	NULL
at	NULL
which	NULL
LTR-luciferase	NULL
reporter	NULL
constructs	NULL
were	NULL
truncated	NULL
is	NULL
also	NULL
marked	NULL
(	NULL
-172	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
DNA	NULL
sequences	NULL
from	NULL
the	NULL
enhancer	NULL
regions	NULL
from	NULL
the	NULL
two	NULL
SIV	NULL
LTRs	NULL
used	NULL
in	NULL
our	NULL
studies	NULL
.	NULL

PBJ9	NULL
corresponds	NULL
to	NULL
the	NULL
AP	NULL
LTR	NULL
,	NULL
while	NULL
PBJB	NULL
is	NULL
the	NULL
NAP	NULL
LTR	NULL
.	NULL

Dots	NULL
represent	NULL
sequence	NULL
identity	NULL
,	NULL
while	NULL
dashes	NULL
denote	NULL
gaps	NULL
introduced	NULL
to	NULL
align	NULL
the	NULL
sequences	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
boxed	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
truncated	NULL
NAP	NULL
and	NULL
AP	NULL
LTRs	NULL
(	NULL
~172	NULL
to	NULL
+321	NULL
)	NULL
differ	NULL
at	NULL
one	NULL
additional	NULL
residue	NULL
not	NULL
shown	NULL
here	NULL
;	NULL
this	NULL
is	NULL
located	NULL
at	NULL
position	NULL
+83	NULL
,	NULL
in	NULL
the	NULL
TAR	NULL
site	NULL
.	NULL

the	NULL
possibility	NULL
of	NULL
recombinational	NULL
mutagenesis	NULL
upon	NULL
later	NULL
transfection	NULL
into	NULL
human	NULL
cells	NULL
.	NULL

The	NULL
full-length	NULL
viruses	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
were	NULL
prepared	NULL
as	NULL
follows	NULL
.	NULL

First	NULL
,	NULL
NAP	NULL
LTR	NULL
elements	NULL
(	NULL
-172	NULL
through	NULL
+102	NULL
;	NULL
StuI-PffMI	NULL
cassette	NULL
)	NULL
were	NULL
substituted	NULL
for	NULL
the	NULL
corresponding	NULL
AP	NULL
LTR	NULL
sequences	NULL
present	NULL
in	NULL
clone	NULL
PBj-5'-1	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
analogous	NULL
LTR	NULL
recombinant	NULL
versions	NULL
of	NULL
the	NULL
3	NULL
'	NULL
genome	NULL
half-clones	NULL
PBj-3'-9	NULL
and	NULL
PBj-3'-b	NULL
were	NULL
constructed	NULL
.	NULL

The	NULL
LTR	NULL
sequences	NULL
exchanged	NULL
in	NULL
this	NULL
fashion	NULL
include	NULL
the	NULL
same	NULL
five	NULL
point	NULL
mutations	NULL
and	NULL
the	NULL
22-bp	NULL
duplication	NULL
that	NULL
were	NULL
included	NULL
in	NULL
the	NULL
truncated	NULL
LTR-luciferase	NULL
reporter	NULL
constructs	NULL
used	NULL
in	NULL
our	NULL
transient	NULL
transfection	NULL
analyses	NULL
.	NULL

For	NULL
generation	NULL
of	NULL
infectious	NULL
SIV	NULL
stocks	NULL
,	NULL
a	NULL
Bcell	NULL
restriction	NULL
site	NULL
was	NULL
used	NULL
to	NULL
linearize	NULL
the	NULL
desired	NULL
5	NULL
and	NULL
3	NULL
'	NULL
SIV	NULL
genome	NULL
halves	NULL
,	NULL
which	NULL
were	NULL
then	NULL
ligated	NULL
to	NULL
one	NULL
another	NULL
and	NULL
transfected	NULL
directly	NULL
into	NULL
U-87MG	NULL
cells	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Lang	NULL
and	NULL
colleagues	NULL
(	NULL
34	NULL
)	NULL
.	NULL

After	NULL
a	NULL
single	NULL
round	NULL
of	NULL
viral	NULL
replication	NULL
in	NULL
U-87MG	NULL
cells	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
CEMX174	NULL
cells	NULL
were	NULL
added	NULL
for	NULL
cocultivation	NULL
,	NULL
and	NULL
virus	NULL
stocks	NULL
were	NULL
prepared	NULL
.	NULL

Virus-containing	NULL
supernatants	NULL
were	NULL
titrated	NULL
by	NULL
serial	NULL
dilution	NULL
in	NULL
CEMX174	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
50	NULL
%	NULL
tissue	NULL
culture	NULL
infectious	NULL
dose	NULL
per	NULL
milliliter	NULL
was	NULL
calculated	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Spearman	NULL
and	NULL
Kirber	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Replication	NULL
studies	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
viral	NULL
stocks	NULL
(	NULL
50	NULL
%	NULL
tissue	NULL
culture	NULL
infectious	NULL
dose	NULL
units	NULL
)	NULL
were	NULL
used	NULL
to	NULL
initiate	NULL
infection	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
CEMX	NULL
174	NULL
and	NULL
C8166	NULL
cells	NULL
(	NULL
multiplicity	NULL
of	NULL
infection	NULL
[	NULL
MOI	NULL
]	NULL
of	NULL
10~*	NULL
)	NULL
.	NULL

Following	NULL
initial	NULL
infection	NULL
,	NULL
kinetics	NULL
of	NULL
viral	NULL
replication	NULL
were	NULL
monitored	NULL
by	NULL
removing	NULL
cell-free	NULL
supernatants	NULL
at	NULL
3-	NULL
to	NULL
4-day	NULL
intervals	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
activity	NULL
in	NULL
these	NULL
supernatants	NULL
was	NULL
determined	NULL
by	NULL
previously	NULL
described	NULL
procedures	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Proliferation	NULL
studies	NULL
.	NULL

Pig-tailed	NULL
macaque	NULL
PBMC	NULL
were	NULL
obtained	NULL
by	NULL
layering	NULL
heparinized	NULL
blood	NULL
from	NULL
SIV-seronegative	NULL
animals	NULL
over	NULL
Ficoll-sodium	NULL
diatrizoate	NULL
density	NULL
gradients	NULL
(	NULL
Phar-macia	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
human	NULL
AB	NULL
serum	NULL
(	NULL
R/HS	NULL
medium	NULL
)	NULL
and	NULL
used	NULL
immediately	NULL
for	NULL
proliferation	NULL
studies	NULL
.	NULL

Briefly	NULL
,	NULL
viral	NULL
supernatants	NULL
(	NULL
MOI	NULL
of	NULL
0.003	NULL
)	NULL
,	NULL
mitogen	NULL
(	NULL
1	NULL
%	NULL
PHA	NULL
plus	NULL
5	NULL
%	NULL
IL-2	NULL
)	NULL
,	NULL
or	NULL
medium	NULL
alone	NULL
was	NULL
added	NULL
to	NULL
10°	NULL
PBMC	NULL
in	NULL
R/HS	NULL
medium	NULL
in	NULL
triplicate	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
6	NULL
days	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

On	NULL
day	NULL
6	NULL
,	NULL
each	NULL
well	NULL
was	NULL
pulsed	NULL
for	NULL
16	NULL
h	NULL
with	NULL
1	NULL
wCi	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
,	NULL
and	NULL
the	NULL
radioactivity	NULL
incorporated	NULL
into	NULL
cellular	NULL
DNA	NULL
was	NULL
quantitated	NULL
.	NULL

RESULTS	NULL
Elevated	NULL
basal	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
AP	NULL
LTR	NULL
from	NULL
SIVimmppji4	NULL
We	NULL
constructed	NULL
LTR-luciferase	NULL
reporter	NULL
plasmids	NULL
in	NULL
which	NULL
either	NULL
intact	NULL
(	NULL
-560	NULL
to	NULL
+321	NULL
)	NULL
or	NULL
truncated	NULL
(	NULL
-172	NULL
to	NULL
+321	NULL
)	NULL
SIV	NULL
LTR	NULL
sequences	NULL
from	NULL
AP	NULL
or	NULL
NAP	NULL
viral	NULL
clones	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
then	NULL
transfected	NULL
transiently	NULL
into	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

Initial	NULL
experiments	NULL
confirmed	NULL
reports	NULL
that	NULL
upstream	NULL
SIV	NULL
LTR	NULL
elements	NULL
are	NULL
dispensable	NULL
for	NULL
near	NULL
normal	NULL
levels	NULL
of	NULL
basal	NULL
,	NULL
mitogen-enhanced	NULL
,	NULL
or	NULL
Tat-transactivated	NULL
LTR	NULL
transcription	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
55	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
all	NULL
subsequent	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
truncated	NULL
LTR	NULL
reporter	NULL
constructs	NULL
.	NULL

The	NULL
AP	NULL
and	NULL
NAP	NULL
LTR	NULL
sequences	NULL
contained	NULL
in	NULL
these	NULL
reporter	NULL
constructs	NULL
(	NULL
-172	NULL
to	NULL
+321	NULL
)	NULL
differ	NULL
by	NULL
only	NULL
five	NULL
point	NULL
mutations	NULL
and	NULL
a	NULL
22-bp	NULL
duplication	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
third	NULL
LTR	NULL
clone	NULL
,	NULL
designated	NULL
NAP-M	NULL
,	NULL
was	NULL
constructed	NULL
and	NULL
tested	NULL
.	NULL

This	NULL
clone	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
NAP	NULL
LTR	NULL
except	NULL
that	NULL
it	NULL
contains	NULL
the	NULL
22-bp	NULL
duplication	NULL
from	NULL
the	NULL
AP	NULL
LTR	NULL
.	NULL

VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
Relative	NULL
luciferase	NULL
activity	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Basal	NULL
LTR	NULL
activity	NULL
.	NULL

The	NULL
indicated	NULL
cell	NULL
lines	NULL
and	NULL
primary	NULL
human	NULL
PBMC	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
AP	NULL
and	NULL
NAP	NULL
luciferase	NULL
plasmids	NULL
.	NULL

The	NULL
values	NULL
of	NULL
all	NULL
NAP	NULL
LTR	NULL
transfections	NULL
were	NULL
normalized	NULL
to	NULL
1	NULL
,	NULL
so	NULL
as	NULL
to	NULL
account	NULL
for	NULL
variations	NULL
in	NULL
transfection	NULL
efficiency	NULL
between	NULL
different	NULL
cells	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
AP	NULL
LTR	NULL
compared	NULL
with	NULL
the	NULL
NAP	NULL
LTR	NULL
in	NULL
each	NULL
cell	NULL
type	NULL
is	NULL
noted	NULL
.	NULL

Values	NULL
presented	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
two	NULL
or	NULL
three	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
standard	NULL
error	NULL
of	NULL
mean	NULL
values	NULL
are	NULL
marked	NULL
by	NULL
bars	NULL
for	NULL
experiments	NULL
that	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
;	NULL
error	NULL
bars	NULL
are	NULL
not	NULL
shown	NULL
for	NULL
experiments	NULL
performed	NULL
only	NULL
twice	NULL
(	NULL
ChM114	NULL
,	NULL
Si-IHA	NULL
,	NULL
and	NULL
U937	NULL
)	NULL
.	NULL

Basal	NULL
LTR-directed	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
cell	NULL
lines	NULL
of	NULL
T-cell	NULL
,	NULL
non-T-cell	NULL
,	NULL
human	NULL
,	NULL
and	NULL
simian	NULL
lineage	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
primary	NULL
human	NULL
PBMC	NULL
.	NULL

The	NULL
LTR	NULL
from	NULL
the	NULL
AP	NULL
strain	NULL
was	NULL
consistently	NULL
more	NULL
active	NULL
than	NULL
the	NULL
LTR	NULL
from	NULL
the	NULL
NAP	NULL
strain	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
while	NULL
the	NULL
NAP-M	NULL
construct	NULL
had	NULL
basal	NULL
activity	NULL
that	NULL
was	NULL
only	NULL
very	NULL
slightly	NULL
less	NULL
than	NULL
that	NULL
of	NULL
the	NULL
AP	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
transcriptional	NULL
activity	NULL
ranged	NULL
from	NULL
2-	NULL
to	NULL
4.5-fold	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
,	NULL
but	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
either	NULL
species	NULL
or	NULL
tissue	NULL
specificity	NULL
.	NULL

Effect	NULL
of	NULL
cytokine	NULL
and	NULL
phorbol	NULL
ester	NULL
on	NULL
transcription	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
LTR	NULL
mutations	NULL
result	NULL
in	NULL
different	NULL
levels	NULL
of	NULL
responsiveness	NULL
to	NULL
cellular	NULL
stimulation	NULL
,	NULL
LTR-luciferase	NULL
constructs	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
PMA	NULL
or	NULL
TNF-	NULL
«	NULL
prior	NULL
to	NULL
determination	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

PMA	NULL
and	NULL
TNF-a	NULL
both	NULL
activate	NULL
NFB	NULL
(	NULL
20	NULL
,	NULL
42	NULL
,	NULL
47	NULL
,	NULL
50	NULL
)	NULL
;	NULL
however	NULL
,	NULL
PMA	NULL
is	NULL
a	NULL
less	NULL
specific	NULL
activator	NULL
of	NULL
NFB	NULL
since	NULL
it	NULL
also	NULL
regulates	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
AP-1	NULL
and	NULL
the	NULL
c-ets	NULL
gene	NULL
products	NULL
(	NULL
28	NULL
,	NULL
36	NULL
,	NULL
65	NULL
,	NULL
66	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
differences	NULL
in	NULL
basal	NULL
transcription	NULL
between	NULL
the	NULL
LTRs	NULL
were	NULL
considerably	NULL
enhanced	NULL
under	NULL
conditions	NULL
of	NULL
cellular	NULL
stimulation	NULL
.	NULL

The	NULL
SIV	NULL
LTRs	NULL
were	NULL
stimulated	NULL
2.2-	NULL
to	NULL
7.8-fold	NULL
over	NULL
basal	NULL
levels	NULL
by	NULL
PMA	NULL
and	NULL
1.9-	NULL
to	NULL
3.6-fold	NULL
over	NULL
basal	NULL
levels	NULL
by	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
level	NULL
of	NULL
stimulation	NULL
is	NULL
slightly	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
when	NULL
an	NULL
HIV-1	NULL
LTR	NULL
reporter	NULL
construct	NULL
was	NULL
used	NULL
(	NULL
this	NULL
clone	NULL
was	NULL
derived	NULL
by	NULL
subcloning	NULL
LTR	NULL
sequences	NULL
from	NULL
pNL432	NULL
into	NULL
pXP1	NULL
)	NULL
.	NULL

The	NULL
HIV-1	NULL
LTR	NULL
was	NULL
stimulated	NULL
10.6-fold	NULL
or	NULL
5.5-fold	NULL
over	NULL
basal	NULL
levels	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
or	NULL
TNF-a	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
however	NULL
,	NULL
transcription	NULL
from	NULL
the	NULL
AP	NULL
SIV	NULL
LTR	NULL
was	NULL
preferentially	NULL
activated	NULL
by	NULL
cellular	NULL
stimulation	NULL
,	NULL
by	NULL
approximately	NULL
two-	NULL
to	NULL
threefold	NULL
relative	NULL
to	NULL
the	NULL
NAP	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
NAP-M	NULL
LTR	NULL
exhibited	NULL
transcriptional	NULL
properties	NULL
quite	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
AP	NULL
LTR	NULL
under	NULL
conditions	NULL
of	NULL
cellular	NULL
stimulation	NULL
and	NULL
in	NULL
fact	NULL
exhibited	NULL
an	NULL
enhanced	NULL
responsiveness	NULL
to	NULL
PMA	NULL
treatment	NULL
relative	NULL
to	NULL
the	NULL
AP	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
strongly	NULL
that	NULL
the	NULL
22-bp	NULL
sequence	NULL
duplication	NULL
confers	NULL
both	NULL
increased	NULL
basal	NULL
transcrip-	NULL
CONTRIBUTION	NULL
OF	NULL
NFkB	NULL
TO	NULL
PHENOTYPE	NULL
OF	NULL
$	NULL
IVinmppia	NULL
_	NULL
7803	NULL
mam	NULL
ArUTR	NULL
ESS	NULL
NAP-M	NULL
LTR	NULL
CCJ	NULL
]	NULL
NAPLTR	NULL
34X	NULL
Basal	NULL
2.TX	NULL
m	NULL
52X	NULL
PMA	NULL
|	NULL
78X	NULL
22X	NULL
p50/p6S	NULL
U	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
Relative	NULL
luciferase	NULL
activity	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

LTR	NULL
response	NULL
to	NULL
cellular	NULL
stimulation	NULL
and	NULL
NFkB	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
AP	NULL
,	NULL
NAP	NULL
,	NULL
or	NULL
NAP-M	NULL
SIV	NULL
LTR-luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
the	NULL
NAP-M	NULL
clone	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
NAP	NULL
LTR	NULL
except	NULL
for	NULL
the	NULL
inclusion	NULL
of	NULL
the	NULL
22-bp	NULL
enhancer	NULL
sequence	NULL
duplication	NULL
from	NULL
the	NULL
AP	NULL
LTR	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
PMA	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
nothing	NULL
prior	NULL
to	NULL
enzyme	NULL
assays	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
some	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
Rel	NULL
family	NULL
proteins	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
,	NULL
which	NULL
together	NULL
comprise	NULL
NFkB	NULL
(	NULL
p50-p65	NULL
)	NULL
.	NULL

Numbers	NULL
shown	NULL
correspond	NULL
to	NULL
either	NULL
the	NULL
fold	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
relative	NULL
to	NULL
the	NULL
unstimulated	NULL
NAP	NULL
LTR	NULL
(	NULL
Basal	NULL
)	NULL
or	NULL
to	NULL
the	NULL
fold	NULL
stimulation	NULL
over	NULL
the	NULL
uninduced	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
for	NULL
each	NULL
of	NULL
the	NULL
LTRs	NULL
tested	NULL
(	NULL
PMA	NULL
,	NULL
TNFa	NULL
,	NULL
and	NULL
p50/p65	NULL
)	NULL
.	NULL

Values	NULL
shown	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
with	NULL
similar	NULL
results	NULL
;	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
mean	NULL
values	NULL
are	NULL
marked	NULL
by	NULL
bars	NULL
.	NULL

tional	NULL
activity	NULL
and	NULL
an	NULL
enhanced	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
cellular	NULL
stimuli	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
with	NULL
PMA	NULL
and	NULL
TNF-a	NULL
were	NULL
confirmed	NULL
by	NULL
additional	NULL
studies	NULL
using	NULL
expression	NULL
plasmids	NULL
encoding	NULL
the	NULL
Rel	NULL
family	NULL
proteins	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
,	NULL
which	NULL
together	NULL
comprise	NULL
NF	NULL
«	NULL
B	NULL
(	NULL
p50-p65	NULL
heterodimer	NULL
[	NULL
58	NULL
]	NULL
)	NULL
.	NULL

When	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
vectors	NULL
were	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
along	NULL
with	NULL
the	NULL
LTR-luciferase	NULL
reporter	NULL
constructs	NULL
,	NULL
there	NULL
was	NULL
a	NULL
6.2-	NULL
to	NULL
22-fold	NULL
induction	NULL
of	NULL
LTR	NULL
activity	NULL
for	NULL
the	NULL
SIV	NULL
LTRs	NULL
and	NULL
a	NULL
16.7-fold	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
.	NULL

Once	NULL
again	NULL
,	NULL
the	NULL
AP	NULL
SIV	NULL
LTR	NULL
was	NULL
preferentially	NULL
activated	NULL
,	NULL
by	NULL
approximately	NULL
threefold	NULL
relative	NULL
to	NULL
the	NULL
NAP	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
NAP-M	NULL
LTR	NULL
behaved	NULL
similarly	NULL
to	NULL
the	NULL
AP	NULL
LTR	NULL
,	NULL
although	NULL
it	NULL
was	NULL
activated	NULL
somewhat	NULL
less	NULL
efficiently	NULL
by	NULL
the	NULL
cloned	NULL
NFxB	NULL
subunits	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Increased	NULL
binding	NULL
to	NULL
the	NULL
NFB	NULL
site	NULL
after	NULL
treatment	NULL
with	NULL
phorbol	NULL
ester	NULL
.	NULL

The	NULL
transient	NULL
transfection	NULL
analyses	NULL
demonstrated	NULL
that	NULL
PMA	NULL
and	NULL
TNF-	NULL
«	NULL
treatment	NULL
led	NULL
to	NULL
elevated	NULL
transcription	NULL
from	NULL
both	NULL
the	NULL
AP	NULL
and	NULL
NAP	NULL
SIV	NULL
LTRs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
to	NULL
confirm	NULL
that	NULL
these	NULL
increases	NULL
in	NULL
transcription	NULL
were	NULL
accompanied	NULL
by	NULL
a	NULL
rise	NULL
in	NULL
nuclear	NULL
levels	NULL
of	NULL
NFB	NULL
.	NULL

Parallel	NULL
cultures	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
treatment	NULL
with	NULL
either	NULL
PMA	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
nothing	NULL
.	NULL

EMSAs	NULL
were	NULL
then	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
by	NULL
using	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
22-bp	NULL
duplication	NULL
found	NULL
in	NULL
the	NULL
SIV.nmppii4	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

This	NULL
22-bp	NULL
DNA	NULL
fragment	NULL
contains	NULL
an	NULL
NFxB	NULL
binding	NULL
site	NULL
as	NULL
well	NULL
as	NULL
an	NULL
overlapping	NULL
site	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
SF3	NULL
(	NULL
67	NULL
)	NULL
.	NULL

To	NULL
differentiate	NULL
between	NULL
these	NULL
factors	NULL
,	NULL
we	NULL
designed	NULL
a	NULL
second	NULL
oligonucleotide	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
mutated	NULL
NFxB	NULL
site	NULL
and	NULL
a	NULL
wild-type	NULL
SF3	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
NFkB	NULL
mutant	NULL
oligonucleotides	NULL
were	NULL
then	NULL
used	NULL
as	NULL
competitors	NULL
in	NULL
gel	NULL
shift	NULL
experiments	NULL
.	NULL

7804	NULL
DOLLARD	NULL
ET	NULL
AL	NULL
.	NULL

|	NULL
mecuononiconmmenane	NULL
.	NULL

A	NULL
)	NULL
NFxB	NULL
wild	NULL
type	NULL
_	NULL
ACAGCAGGGACTTTCCACAAAG	NULL
[	NULL
__	NULL
1	NULL
NFxB	NULL
mutant	NULL
ACAGCACTCACTTTCCACAAAG	NULL
B	NULL
)	NULL
Control	NULL
+PMA	NULL
+TNFa	NULL
protein	NULL
[	NULL
+	NULL
+	NULL
+l	NULL
[	NULL
+	NULL
O+	NULL
+	NULL
]	NULL
[	NULL
+	NULL
+	NULL
+	NULL
]	NULL
competitor	NULL
w	NULL
M-	NULL
W	NULL
M	NULL
Ww	NULL
-	NULL
M	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
NFKB	NULL
'SF3	NULL
``	NULL
bows	NULL
``	NULL
U2	NULL
N.S	NULL
.	NULL

--	NULL
-I	NULL
»	NULL
Free	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

EMSA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Double-stranded	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
22-bp	NULL
enhancer	NULL
sequence	NULL
that	NULL
is	NULL
in	NULL
tandem	NULL
duplication	NULL
in	NULL
SIVinmppii	NULL
,	NULL
were	NULL
synthesized	NULL
.	NULL

Wild-type	NULL
DNA	NULL
was	NULL
end	NULL
labeled	NULL
,	NULL
and	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
mutant	NULL
DNAs	NULL
were	NULL
used	NULL
for	NULL
competition	NULL
experiments	NULL
;	NULL
the	NULL
latter	NULL
has	NULL
been	NULL
shown	NULL
not	NULL
to	NULL
bind	NULL
NFkB	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Underlined	NULL
sequences	NULL
denote	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
NFB	NULL
,	NULL
brackets	NULL
mark	NULL
the	NULL
SF3	NULL
binding	NULL
site	NULL
(	NULL
67	NULL
)	NULL
,	NULL
and	NULL
mutated	NULL
bases	NULL
are	NULL
shown	NULL
in	NULL
outline	NULL
form	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
reaction	NULL
mixtures	NULL
contained	NULL
10	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
simultaneously	NULL
from	NULL
PMA-	NULL
or	NULL
TNF-	NULL
«	NULL
-stimulated	NULL
or	NULL
unstimulated	NULL
Jurkat	NULL
cultures	NULL
,	NULL
10,000	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
DNA	NULL
,	NULL
and	NULL
,	NULL
in	NULL
some	NULL
cases	NULL
,	NULL
unlabeled	NULL
competitor	NULL
DNA	NULL
.	NULL

Arrows	NULL
indicate	NULL
NFB	NULL
and	NULL
(	NULL
putative	NULL
)	NULL
SF3	NULL
complexes	NULL
;	NULL
N.S	NULL
.	NULL

,	NULL
a	NULL
nonspecific	NULL
DNA-protein	NULL
complex	NULL
that	NULL
was	NULL
not	NULL
competed	NULL
for	NULL
by	NULL
unlabeled	NULL
DNA	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
no	NULL
nuclear	NULL
extract	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
have	NULL
no	NULL
competitor	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
have	NULL
a	NULL
25-fold	NULL
molar	NULL
excess	NULL
of	NULL
wild-type	NULL
(	NULL
W	NULL
)	NULL
competitor	NULL
;	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
have	NULL
a	NULL
25-fold	NULL
molar	NULL
excess	NULL
of	NULL
mutant	NULL
(	NULL
M	NULL
)	NULL
competitor	NULL
.	NULL

In	NULL
PMA-	NULL
and	NULL
TNF-o-stimulated	NULL
cultures	NULL
,	NULL
two	NULL
shifted	NULL
bands	NULL
were	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
had	NULL
the	NULL
same	NULL
mobility	NULL
as	NULL
a	NULL
band	NULL
that	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
cultures	NULL
and	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
both	NULL
the	NULL
wild-type	NULL
and	NULL
NFkB	NULL
mutant	NULL
oligonucleotides	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
cells	NULL
and	NULL
was	NULL
competed	NULL
for	NULL
with	NULL
wild-type	NULL
DNA	NULL
but	NULL
not	NULL
with	NULL
NFkB	NULL
mutant	NULL
DNA	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
lower	NULL
band	NULL
corresponds	NULL
to	NULL
the	NULL
constitutive	NULL
transcription	NULL
factor	NULL
SF3	NULL
,	NULL
while	NULL
the	NULL
upper	NULL
band	NULL
represents	NULL
NFkB	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
intriguing	NULL
that	NULL
the	NULL
putative	NULL
SF3	NULL
binding	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
induced	NULL
in	NULL
Jurkat	NULL
cells	NULL
by	NULL
TNF-	NULL
«	NULL
treatment	NULL
but	NULL
not	NULL
by	NULL
PMA	NULL
.	NULL

EMSA	NULL
analysis	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
SW480	NULL
and	NULL
J-Jahn	NULL
cells	NULL
suggest	NULL
that	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
this	NULL
factor	NULL
may	NULL
also	NULL
vary	NULL
between	NULL
different	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transactivation	NULL
by	NULL
viral	NULL
Tat	NULL
.	NULL

Tat-coding	NULL
sequences	NULL
from	NULL
both	NULL
AP	NULL
and	NULL
NAP	NULL
clones	NULL
of	NULL
SIV	NULL
...	NULL
.ps	NULL
;	NULL
1	NULL
,	NULL
were	NULL
cloned	NULL
into	NULL
a	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
to	NULL
examine	NULL
whether	NULL
there	NULL
is	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
transactivation	NULL
mediated	NULL
by	NULL
the	NULL
two	NULL
SIV	NULL
Tat	NULL
proteins	NULL
.	NULL

A	NULL
second	NULL
goal	NULL
of	NULL
these	NULL
experiments	NULL
was	NULL
to	NULL
determine	NULL
whether	NULL
there	NULL
was	NULL
any	NULL
difference	NULL
in	NULL
the	NULL
responses	NULL
of	NULL
the	NULL
AP	NULL
and	NULL
NAP	NULL
LTRs	NULL
to	NULL
Tat-mediated	NULL
transactivation	NULL
,	NULL
as	NULL
was	NULL
described	NULL
for	NULL
the	NULL
LTRs	NULL
from	NULL
SIV	NULL
,	NULL
,4c142	NULL
aDd	NULL
SIV	NULL
DY	NULL
Anderson	NULL
and	NULL
Clements	NULL
(	NULL
3	NULL
)	NULL
.	NULL

LTR-luciferase	NULL
reporter	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
Jur-	NULL
J.	NULL
ViroL	NULL
.	NULL

NaP	NULL
HB	NULL
NAP-Tat	NULL
CJ	NULL
NoTat	NULL
I	NULL
U	NULL
0	NULL
50	NULL
100	NULL
150	NULL
Relative	NULL
Luciferase	NULL
activity	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

LTR	NULL
transactivation	NULL
by	NULL
SIV	NULL
Tat	NULL
.	NULL

Human	NULL
T	NULL
cells	NULL
(	NULL
Jurkat	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
AP	NULL
and	NULL
NAP	NULL
LTR	NULL
luciferase	NULL
plasmids	NULL
and	NULL
either	NULL
the	NULL
AP	NULL
or	NULL
NAP	NULL
Tat	NULL
expression	NULL
vector	NULL
or	NULL
the	NULL
vector	NULL
with	NULL
no	NULL
insert	NULL
(	NULL
pUC19	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
values	NULL
for	NULL
the	NULL
NAP	NULL
LTR	NULL
were	NULL
normalized	NULL
to	NULL
1	NULL
in	NULL
all	NULL
experiments	NULL
;	NULL
other	NULL
datum	NULL
points	NULL
are	NULL
expressed	NULL
as	NULL
multiples	NULL
of	NULL
this	NULL
.	NULL

Numbers	NULL
shown	NULL
correspond	NULL
to	NULL
the	NULL
fold	NULL
stimulation	NULL
over	NULL
the	NULL
uninduced	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
for	NULL
each	NULL
of	NULL
the	NULL
LTR-Tat	NULL
combinations	NULL
tested	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
with	NULL
similar	NULL
results	NULL
;	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
mean	NULL
values	NULL
are	NULL
marked	NULL
by	NULL
bars	NULL
.	NULL

kat	NULL
cells	NULL
together	NULL
with	NULL
one	NULL
of	NULL
the	NULL
Tat	NULL
expression	NULL
plasmids	NULL
or	NULL
with	NULL
the	NULL
pUC19	NULL
vector	NULL
.	NULL

The	NULL
two	NULL
SIV	NULL
Tat	NULL
protein	NULL
expression	NULL
vectors	NULL
conferred	NULL
essentially	NULL
indistinguishable	NULL
levels	NULL
of	NULL
transactivation	NULL
on	NULL
the	NULL
SIV	NULL
LTR	NULL
reporter	NULL
constructs	NULL
,	NULL
and	NULL
the	NULL
two	NULL
LTRs	NULL
were	NULL
equally	NULL
Tat	NULL
responsive	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
point	NULL
mutation	NULL
at	NULL
residue	NULL
+83	NULL
in	NULL
the	NULL
AP	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Enhancer	NULL
activity	NULL
of	NULL
the	NULL
22-bp	NULL
LTR	NULL
repeat	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
duplicated	NULL
LTR	NULL
sequences	NULL
in	NULL
SIV.nnpp	NULL
;	NULL
i	NULL
,	NULL
have	NULL
intrinsic	NULL
enhancer	NULL
activity	NULL
,	NULL
oligonucleotides	NULL
similar	NULL
to	NULL
those	NULL
used	NULL
in	NULL
EMSA	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pSlucZ2	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
48	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
contains	NULL
an	NULL
enhancerless	NULL
SV40	NULL
promoter	NULL
which	NULL
has	NULL
multiple	NULL
Sp1	NULL
binding	NULL
sites	NULL
,	NULL
like	NULL
the	NULL
SIV	NULL
LTR	NULL
.	NULL

Both	NULL
one	NULL
and	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
22-bp	NULL
LTR	NULL
repeat	NULL
from	NULL
SIV	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
in	NULL
both	NULL
wild-type	NULL
and	NULL
NFkB	NULL
mutant	NULL
versions	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
then	NULL
transfected	NULL
into	NULL
SW480	NULL
cells	NULL
,	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

A	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
22-bp	NULL
LTR	NULL
sequence	NULL
,	NULL
either	NULL
wild	NULL
type	NULL
or	NULL
NFB	NULL
mutant	NULL
,	NULL
had	NULL
transcriptional	NULL
activity	NULL
approximately	NULL
fivefold	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
the	NULL
vector	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Presumably	NULL
,	NULL
the	NULL
modest	NULL
enhancer	NULL
activity	NULL
from	NULL
these	NULL
single-copy	NULL
clones	NULL
reflects	NULL
SF3-mediated	NULL
transcriptional	NULL
enhancement	NULL
,	NULL
since	NULL
the	NULL
SF3	NULL
binding	NULL
motif	NULL
is	NULL
intact	NULL
in	NULL
both	NULL
the	NULL
wild-type	NULL
and	NULL
NFkB	NULL
mutant	NULL
oligonucleotides	NULL
.	NULL

When	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
22-bp	NULL
SIV	NULL
inmppji4	NULL
LTR	NULL
motif	NULL
were	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
transcriptional	NULL
enhancement	NULL
was	NULL
detected	NULL
(	NULL
approximately	NULL
fivefold	NULL
higher	NULL
than	NULL
for	NULL
the	NULL
single-copy	NULL
clone	NULL
;	NULL
compare	NULL
pWR1	NULL
and	NULL
pWR2	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
additional	NULL
increase	NULL
in	NULL
transcriptional	NULL
activity	NULL
was	NULL
completely	NULL
abolished	NULL
,	NULL
however	NULL
,	NULL
when	NULL
the	NULL
NFB	NULL
binding	NULL
site	NULL
was	NULL
mutated	NULL
(	NULL
compare	NULL
pMR1	NULL
and	NULL
pMR2	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Replication	NULL
of	NULL
LTR	NULL
recombinant	NULL
SIVs	NULL
in	NULL
continuous	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
constructed	NULL
two	NULL
pairs	NULL
of	NULL
SIVs	NULL
that	NULL
were	NULL
isogenic	NULL
except	NULL
for	NULL
their	NULL
LTR	NULL
elements	NULL
(	NULL
-172	NULL
through	NULL
+102	NULL
)	NULL
.	NULL

These	NULL
virus	NULL
pairs	NULL
were	NULL
designed	NULL
to	NULL
allow	NULL
us	NULL
to	NULL
test	NULL
the	NULL
effects	NULL
of	NULL
LTR	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
env	NULL
(	NULL
and	NULL
accessory	NULL
)	NULL
genes	NULL
from	NULL
both	NULL
AP	NULL
and	NULL
NAP	NULL
derivatives	NULL
Of	NULL
SIV.nmppiia	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
LTR	NULL
sequences	NULL
that	NULL
were	NULL
exchanged	NULL
in	NULL
these	NULL
SIV	NULL
recombi-nants	NULL
were	NULL
carefully	NULL
chosen	NULL
so	NULL
as	NULL
to	NULL
include	NULL
all	NULL
of	NULL
the	NULL
differences	NULL
between	NULL
the	NULL
NAP	NULL
and	NULL
AP	NULL
LTRs	NULL
in	NULL
the	NULL
US	NULL
,	NULL
R	NULL
,	NULL
and	NULL
promoter-proximal	NULL
half	NULL
of	NULL
U3	NULL
(	NULL
there	NULL
are	NULL
no	NULL
differences	NULL
between	NULL
these	NULL
LTRs	NULL
in	NULL
the	NULL
region	NULL
+102	NULL
through	NULL
+321	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
full-length	NULL
SIVs	NULL
were	NULL
designed	NULL
to	NULL
allow	NULL
comparison	NULL
of	NULL
the	NULL
VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
Insert	NULL
DNA	NULL
pSluc2	NULL
I	NULL
pPMR1	NULL
£	NULL
|	NULL
fF	NULL
six	NULL
pWRI1	NULL
SBR	NULL
1	NULL
53X	NULL
pMR2	NULL
A	NULL
pWR2	NULL
ﬁn	NULL
xB	NULL
SF3	NULL
0	NULL
10	NULL
20	NULL
30	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
22-bp	NULL
enhancer	NULL
element	NULL
in	NULL
SW480	NULL
cells	NULL
.	NULL

Clones	NULL
pWR1	NULL
and	NULL
pWR2	NULL
contain	NULL
one	NULL
and	NULL
two	NULL
copies	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
the	NULL
22-bp	NULL
LTR	NULL
element	NULL
from	NULL
SIV.napp	NULL
;	NULL
i4	NULL
,	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
enhancerless	NULL
promoter	NULL
and	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
pSluc2	NULL
.	NULL

Clones	NULL
pMR1	NULL
and	NULL
pMR2	NULL
contain	NULL
one	NULL
and	NULL
two	NULL
copies	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
a	NULL
derivative	NULL
of	NULL
this	NULL
sequence	NULL
in	NULL
which	NULL
the	NULL
NFxB	NULL
site	NULL
(	NULL
s	NULL
)	NULL
has	NULL
been	NULL
mutated	NULL
so	NULL
as	NULL
to	NULL
abolish	NULL
its	NULL
function	NULL
(	NULL
GGG-CTC	NULL
)	NULL
,	NULL
while	NULL
the	NULL
adjacent	NULL
SF3	NULL
site	NULL
(	NULL
s	NULL
)	NULL
has	NULL
been	NULL
left	NULL
intact	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Numbers	NULL
shown	NULL
correspond	NULL
to	NULL
the	NULL
fold	NULL
stimulation	NULL
over	NULL
the	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
for	NULL
the	NULL
vector	NULL
alone	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
with	NULL
similar	NULL
results	NULL
;	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
mean	NULL
values	NULL
are	NULL
marked	NULL
by	NULL
bars	NULL
.	NULL

biologic	NULL
effects	NULL
of	NULL
the	NULL
same	NULL
LTR	NULL
mutations	NULL
that	NULL
were	NULL
previously	NULL
compared	NULL
in	NULL
our	NULL
truncated	NULL
LTR-luciferase	NULL
reporter	NULL
constructs	NULL
(	NULL
these	NULL
contain	NULL
LTR	NULL
sequences	NULL
from	NULL
-172	NULL
through	NULL
+321	NULL
)	NULL
.	NULL

Infectious	NULL
SIVs	NULL
were	NULL
generated	NULL
by	NULL
transfection	NULL
of	NULL
ligated	NULL
SIV	NULL
genome	NULL
halves	NULL
into	NULL
U-87MG	NULL
cells	NULL
,	NULL
followed	NULL
by	NULL
cocultiva-tion	NULL
with	NULL
CEMX174	NULL
cells	NULL
to	NULL
generate	NULL
virus	NULL
stocks	NULL
.	NULL

SIV	NULL
stocks	NULL
were	NULL
then	NULL
used	NULL
to	NULL
infect	NULL
the	NULL
SIV-susceptible	NULL
lymphoid	NULL
cell	NULL
lines	NULL
CEM	NULL
X	NULL
174	NULL
(	NULL
a	NULL
B-cell/T-cell	NULL
hybrid	NULL
)	NULL
and	NULL
C8166	NULL
(	NULL
an	NULL
HTLV-I-transformed	NULL
T	NULL
cell	NULL
)	NULL
at	NULL
an	NULL
MOI	NULL
of	NULL
10~*	NULL
.	NULL

In	NULL
CEMX174	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
,	NULL
all	NULL
four	NULL
recombinant	NULL
SIVs	NULL
replicated	NULL
to	NULL
similar	NULL
levels	NULL
at	NULL
later	NULL
time	NULL
points	NULL
(	NULL
days	NULL
18	NULL
through	NULL
25	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
early	NULL
time	NULL
points	NULL
(	NULL
day	NULL
10	NULL
)	NULL
,	NULL
there	NULL
was	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
replication	NULL
by	NULL
the	NULL
two	NULL
SIVs	NULL
which	NULL
contained	NULL
the	NULL
AP	NULL
LTR	NULL
elements	NULL
(	NULL
DEW-1	NULL
and	NULL
DEW-3	NULL
)	NULL
compared	NULL
with	NULL
their	NULL
otherwise	NULL
isogenic	NULL
counterparts	NULL
(	NULL
DEW-2	NULL
and	NULL
DEW-4	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
for	NULL
C8166	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
3	NULL
'	NULL
genome	NULL
half	NULL
sequences	NULL
from	NULL
NAP	NULL
virus	NULL
clones	NULL
conferred	NULL
a	NULL
significant	NULL
growth	NULL
advantage	NULL
(	NULL
compare	NULL
clones	NULL
DEW-3	NULL
and	NULL
DEW-4	NULL
with	NULL
clones	NULL
DEW-1	NULL
and	NULL
DEW-2	NULL
)	NULL
.	NULL

This	NULL
difference	NULL
presumably	NULL
reflects	NULL
an	NULL
alteration	NULL
in	NULL
virus	NULL
cell	NULL
tropism	NULL
,	NULL
mostly	NULL
likely	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
env	NULL
gene	NULL
.	NULL

Ability	NULL
of	NULL
LTR	NULL
recombinant	NULL
SIVs	NULL
to	NULL
trigger	NULL
proliferation	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
SIV	NULL
;	NULL
...	NULL
..pg	NULL
;	NULL
1	NULL
4	NULL
,	NULL
and	NULL
molecular	NULL
clones	NULL
derived	NULL
from	NULL
it	NULL
,	NULL
to	NULL
induce	NULL
proliferation	NULL
in	NULL
resting	NULL
PBMC	NULL
from	NULL
LTR	NULL
5	NULL
(	NULL
ga	NULL
;	NULL
CONTRIBUTION	NULL
OF	NULL
NFkB	NULL
TO	NULL
PHENOTYPE	NULL
OF	NULL
$	NULL
IVimmppia	NULL
-	NULL
7805	NULL
pig-tailed	NULL
macaques	NULL
is	NULL
unique	NULL
among	NULL
SIVs	NULL
and	NULL
is	NULL
a	NULL
highly	NULL
predictive	NULL
correlate	NULL
of	NULL
acute	NULL
pathogenicity	NULL
in	NULL
vivo	NULL
(	NULL
24	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Infection	NULL
of	NULL
resting	NULL
pig-tailed	NULL
macaque	NULL
PBMC	NULL
with	NULL
the	NULL
recombinant	NULL
SIVs	NULL
was	NULL
therefore	NULL
performed	NULL
,	NULL
and	NULL
cellular	NULL
proliferation	NULL
was	NULL
measured	NULL
at	NULL
6	NULL
days	NULL
after	NULL
infection	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Novembre	NULL
et	NULL
al	NULL
.	NULL

(	NULL
49	NULL
)	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
four	NULL
recombinant	NULL
SIVs	NULL
tested	NULL
,	NULL
DEW-1	NULL
and	NULL
DEW-2	NULL
,	NULL
induced	NULL
cellular	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

These	NULL
contain	NULL
both	NULL
gag	NULL
and	NULL
env	NULL
elements	NULL
from	NULL
AP	NULL
clones	NULL
of	NULL
SIV.nappii	NULL
,	NULL
whereas	NULL
clones	NULL
DEW-3	NULL
and	NULL
DEW-4	NULL
lack	NULL
the	NULL
AP	NULL
env	NULL
elements	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
cellular	NULL
proliferation	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
that	NULL
DEW-1	NULL
induced	NULL
a	NULL
level	NULL
of	NULL
cellular	NULL
proliferation	NULL
two-	NULL
to	NULL
threefold	NULL
higher	NULL
than	NULL
than	NULL
produced	NULL
by	NULL
the	NULL
DEW-2	NULL
virus	NULL
.	NULL

This	NULL
finding	NULL
indicates	NULL
that	NULL
AP	NULL
LTR	NULL
elements	NULL
can	NULL
significantly	NULL
enhance	NULL
an	NULL
important	NULL
phenotypic	NULL
property	NULL
of	NULL
SI	NULL
‘	NULL
1smmPBj	NULL
14°	NULL
DISCUSSION	NULL
We	NULL
previously	NULL
reported	NULL
isolation	NULL
and	NULL
sequence	NULL
analysis	NULL
of	NULL
a	NULL
variant	NULL
of	NULL
SIV	NULL
referred	NULL
to	NULL
as	NULL
SIV	NULL
.	NULL

,	NULL
...	NULL
pp	NULL
;	NULL
1	NULL
,	NULL
that	NULL
is	NULL
unlike	NULL
any	NULL
all	NULL
other	NULL
primate	NULL
lentiviruses	NULL
in	NULL
causing	NULL
acute	NULL
disease	NULL
and	NULL
death	NULL
1	NULL
to	NULL
2	NULL
weeks	NULL
postinfection	NULL
(	NULL
25	NULL
)	NULL
.	NULL

One	NULL
of	NULL
the	NULL
most	NULL
striking	NULL
genetic	NULL
differences	NULL
between	NULL
and	NULL
other	NULL
viruses	NULL
belonging	NULL
to	NULL
the	NULL
SIV	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
HIV-2	NULL
group	NULL
is	NULL
in	NULL
the	NULL
LTR	NULL
enhancer	NULL
element	NULL
;	NULL
SIV	NULL
:	NULL
mmppii1	NULL
has	NULL
a	NULL
tandem	NULL
sequence	NULL
duplication	NULL
that	NULL
contains	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
transcription	NULL
factor	NULL
NFkB	NULL
(	NULL
12	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
other	NULL
molecular	NULL
clones	NULL
of	NULL
SIV	NULL
have	NULL
determined	NULL
that	NULL
the	NULL
viral	NULL
determinants	NULL
of	NULL
acute	NULL
disease	NULL
induction	NULL
map	NULL
to	NULL
multiple	NULL
genetic	NULL
loci	NULL
,	NULL
including	NULL
the	NULL
env	NULL
and	NULL
gag	NULL
genes	NULL
(	NULL
49	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
analogous	NULL
to	NULL
those	NULL
for	NULL
the	NULL
feline	NULL
leukemia	NULL
virus	NULL
model	NULL
for	NULL
AIDS	NULL
,	NULL
in	NULL
which	NULL
viral	NULL
determinants	NULL
of	NULL
pathogenicity	NULL
were	NULL
also	NULL
mapped	NULL
to	NULL
several	NULL
gene	NULL
segments	NULL
,	NULL
including	NULL
the	NULL
env	NULL
gene	NULL
and	NULL
the	NULL
LTR	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Because	NULL
SIV	NULL
immppji4	NULL
has	NULL
unique	NULL
replicative	NULL
properties	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
define	NULL
precisely	NULL
the	NULL
effects	NULL
that	NULL
the	NULL
two	NULL
NFkB	NULL
sites	NULL
had	NULL
on	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
this	NULL
virus	NULL
's	NULL
LTR	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
the	NULL
basal	NULL
transcriptional	NULL
activity	NULL
of	NULL
an	NULL
LTR	NULL
derived	NULL
from	NULL
an	NULL
AP	NULL
molecular	NULL
clone	NULL
Of	NULL
$	NULL
IVimmppji1a	NULL
iS	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
a	NULL
prototype	NULL
SIV	NULL
.	NULL

,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
LTR	NULL
,	NULL
derived	NULL
from	NULL
an	NULL
NAP	NULL
virus	NULL
stock	NULL
.	NULL

These	NULL
LTRs	NULL
differ	NULL
by	NULL
only	NULL
five	NULL
point	NULL
muta-tions	NULL
,	NULL
four	NULL
of	NULL
which	NULL
map	NULL
to	NULL
the	NULL
LTR	NULL
enhancer	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
22-bp	NULL
sequence	NULL
duplication	NULL
that	NULL
contains	NULL
an	NULL
NFB	NULL
binding	NULL
site	NULL
.	NULL

Basal	NULL
transcription	NULL
from	NULL
the	NULL
AP	NULL
SIV	NULL
LTR	NULL
was	NULL
consistently	NULL
2-	NULL
to	NULL
4.5-fold	NULL
higher	NULL
than	NULL
that	NULL
from	NULL
the	NULL
NAP	NULL
LTR	NULL
,	NULL
regardless	NULL
of	NULL
cell	NULL
type	NULL
or	NULL
species	NULL
of	NULL
origin	NULL
.	NULL

This	NULL
difference	NULL
was	NULL
found	NULL
in	NULL
primary	NULL
cells	NULL
(	NULL
human	NULL
PBMC	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
cell	NULL
lines	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
increased	NULL
level	NULL
of	NULL
basal	NULL
transcription	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
due	NULL
in	NULL
large	NULL
part	NULL
to	NULL
the	NULL
22-bp	NULL
enhancer	NULL
sequence	NULL
duplica-tion	NULL
,	NULL
since	NULL
addition	NULL
of	NULL
this	NULL
element	NULL
to	NULL
the	NULL
NAP	NULL
LTR	NULL
resulted	NULL
3	NULL
'	NULL
(	NULL
env	NULL
)	NULL
LTR	NULL
mp	NULL
>	NULL
ev	NULL
Comme	NULL
)	NULL
-	NULL
>	NULL
a	NULL
Parent	NULL
NAP	NULL
clone	NULL
ym	NULL
~~~	NULL
W	NULL
>	NULL
asin	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

LTR	NULL
recombinant	NULL
SIVs	NULL
.	NULL

Full-length	NULL
recombinant	NULL
SIVs	NULL
with	NULL
the	NULL
indicated	NULL
genomic	NULL
composition	NULL
were	NULL
derived	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

7806	NULL
DOLLARD	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
:	NULL
CEM174	NULL
100000-	NULL
Reverse	NULL
Transcriptase	NULL
Activity	NULL
(	NULL
cpm/ml	NULL
)	NULL
10000-	NULL
0	NULL
5	NULL
10	NULL
15	NULL
_	NULL
20	NULL
Days	NULL
post	NULL
infection	NULL
It	NULL
--	NULL
T	NULL
OOT	NULL
-T	NULL
-T	NULL
O1	NULL
J.	NULL
Viror	NULL
.	NULL

B	NULL
:	NULL
C8166	NULL
10000007	NULL
100007	NULL
-T	NULL
3	NULL
0	NULL
U	NULL
10	NULL
15	NULL
20	NULL
25	NULL
Days	NULL
post	NULL
infection	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Replication	NULL
kinetics	NULL
of	NULL
recombinant	NULL
SIVs	NULL
.	NULL

Human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
CEM	NULL
x	NULL
174	NULL
and	NULL
C8166	NULL
)	NULL
were	NULL
infected	NULL
with	NULL
recombinant	NULL
SIVs	NULL
at	NULL
an	NULL
MOI	NULL
of	NULL
10~*	NULL
,	NULL
and	NULL
reverse	NULL
transcriptase	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
cell-free	NULL
culture	NULL
supernatants	NULL
at	NULL
timed	NULL
intervals	NULL
thereafter	NULL
.	NULL

The	NULL
filled	NULL
symbols	NULL
represent	NULL
viruses	NULL
with	NULL
AP	NULL
LTR	NULL
elements	NULL
(	NULL
DEW-1	NULL
[	NULL
M	NULL
)	NULL
and	NULL
DEW-3	NULL
[	NULL
a	NULL
]	NULL
)	NULL
,	NULL
while	NULL
the	NULL
corresponding	NULL
open	NULL
symbols	NULL
represent	NULL
isogenic	NULL
viruses	NULL
with	NULL
NAP	NULL
LTRs	NULL
(	NULL
DEW-2	NULL
[	NULL
0	NULL
]	NULL
and	NULL
DEW-4	NULL
[	NULL
+	NULL
]	NULL
)	NULL
.	NULL

Dark	NULL
lines	NULL
are	NULL
used	NULL
to	NULL
further	NULL
distinguish	NULL
the	NULL
DEW-1/DEW-2	NULL
virus	NULL
pair	NULL
from	NULL
the	NULL
DEW-3/DEW-4	NULL
virus	NULL
pair	NULL
(	NULL
lighter	NULL
lines	NULL
)	NULL
.	NULL

The	NULL
open	NULL
circles	NULL
represent	NULL
negative	NULL
control	NULL
cultures	NULL
(	NULL
no	NULL
virus	NULL
added	NULL
)	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
mean	NULL
reverse	NULL
transcriptase	NULL
data	NULL
for	NULL
three	NULL
(	NULL
CEM	NULL
or	NULL
two	NULL
(	NULL
C8166	NULL
)	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

in	NULL
a	NULL
clone	NULL
(	NULL
NAP-M	NULL
)	NULL
with	NULL
basal	NULL
transcriptional	NULL
activity	NULL
that	NULL
was	NULL
only	NULL
slightly	NULL
less	NULL
than	NULL
that	NULL
of	NULL
the	NULL
AP	NULL
LTR	NULL
.	NULL

Experiments	NULL
designed	NULL
to	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
cellular	NULL
stimulation	NULL
on	NULL
SIV	NULL
LTR-directed	NULL
transcription	NULL
showed	NULL
that	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
or	NULL
TNF-a	NULL
,	NULL
or	NULL
when	NULL
they	NULL
were	NULL
cotransfected	NULL
with	NULL
p50/p65	NULL
NFB	NULL
subunit	NULL
expression	NULL
vectors	NULL
,	NULL
there	NULL
was	NULL
a	NULL
significant	NULL
rise	NULL
in	NULL
LTR	NULL
transcription	NULL
relative	NULL
to	NULL
basal	NULL
levels	NULL
.	NULL

The	NULL
AP	NULL
LTR	NULL
was	NULL
induced	NULL
to	NULL
a	NULL
greater	NULL
(	NULL
two-	NULL
to	NULL
threefold	NULL
)	NULL
extent	NULL
than	NULL
the	NULL
NAP	NULL
LTR	NULL
by	NULL
all	NULL
of	NULL
these	NULL
treatments	NULL
.	NULL

We	NULL
determined	NULL
whether	NULL
the	NULL
duplicated	NULL
enhancer	NULL
element	NULL
in	NULL
the	NULL
AP	NULL
LTR	NULL
from	NULL
was	NULL
required	NULL
for	NULL
responsiveness	NULL
to	NULL
cellular	NULL
stimulation	NULL
by	NULL
using	NULL
the	NULL
NAP-M	NULL
LTR	NULL
clone	NULL
.	NULL

This	NULL
clone	NULL
was	NULL
induced	NULL
to	NULL
a	NULL
somewhat	NULL
higher	NULL
level	NULL
by	NULL
PMA	NULL
than	NULL
either	NULL
of	NULL
the	NULL
parental	NULL
LTRs	NULL
,	NULL
while	NULL
its	NULL
responsiveness	NULL
to	NULL
the	NULL
cloned	NULL
NFB	NULL
subunits	NULL
p50	NULL
and	NULL
p65	NULL
was	NULL
slightly	NULL
reduced	NULL
relative	NULL
to	NULL
the	NULL
AP	NULL
LTR	NULL
.	NULL

The	NULL
minor	NULL
difference	NULL
in	NULL
PMA	NULL
responsiveness	NULL
may	NULL
reflect	NULL
the	NULL
binding	NULL
of	NULL
PMA-induced	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
the	NULL
Elf-1	NULL
protein	NULL
(	NULL
36	NULL
)	NULL
,	NULL
to	NULL
the	NULL
putative	NULL
PuB2	NULL
element	NULL
(	NULL
AGGAA	NULL
consensus	NULL
motif	NULL
)	NULL
in	NULL
the	NULL
NAP	NULL
LTR	NULL
,	NULL
since	NULL
this	NULL
element	NULL
is	NULL
absent	NULL
in	NULL
the	NULL
AP	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
AP	NULL
and	NULL
NAP-M	NULL
LTRs	NULL
responded	NULL
almost	NULL
equally	NULL
to	NULL
TNF-a	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
cloned	NULL
NFkB	NULL
subunits	NULL
p65	NULL
and	NULL
p50	NULL
,	NULL
was	NULL
somewhat	NULL
unexpected	NULL
.	NULL

Presumably	NULL
,	NULL
this	NULL
reflects	NULL
(	NULL
i	NULL
)	NULL
an	NULL
interaction	NULL
between	NULL
NFB	NULL
subunits	NULL
p65	NULL
and	NULL
p50	NULL
and	NULL
an	NULL
unknown	NULL
cellular	NULL
factor	NULL
which	NULL
binds	NULL
preferentially	NULL
to	NULL
either	NULL
the	NULL
NAP	NULL
or	NULL
AP	NULL
LTR	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
fact	NULL
that	NULL
TNF-	NULL
«	NULL
activates	NULL
several	NULL
NFkB	NULL
proteins	NULL
in	NULL
addition	NULL
to	NULL
p65	NULL
and	NULL
p50	NULL
(	NULL
6	NULL
)	NULL
.	NULL

We	NULL
also	NULL
performed	NULL
parallel	NULL
studies	NULL
in	NULL
which	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
the	NULL
duplicated	NULL
22-bp	NULL
LTR	NULL
sequence	NULL
from	NULL
the	NULL
AP	NULL
LTR	NULL
from	NULL
SIV	NULL
;	NULL
..pg	NULL
;	NULL
i	NULL
,	NULL
were	NULL
analyzed	NULL
.	NULL

These	NULL
included	NULL
experiments	NULL
designed	NULL
to	NULL
differentiate	NULL
the	NULL
relative	NULL
contributions	NULL
of	NULL
the	NULL
two	NULL
overlapping	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
(	NULL
SF3	NULL
and	NULL
NFxB	NULL
)	NULL
contained	NULL
within	NULL
the	NULL
22-bp	NULL
DNA	NULL
fragment	NULL
.	NULL

Two	NULL
copies	NULL
of	NULL
the	NULL
22-bp	NULL
LTR	NULL
element	NULL
had	NULL
significantly	NULL
(	NULL
fivefold	NULL
)	NULL
elevated	NULL
transcription-enhancing	NULL
activity	NULL
,	NULL
when	NULL
placed	NULL
upstream	NULL
of	NULL
an	NULL
enhancerless	NULL
promoter	NULL
,	NULL
relative	NULL
to	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
same	NULL
element	NULL
.	NULL

This	NULL
level	NULL
of	NULL
enhancement	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
difference	NULL
in	NULL
basal	NULL
transcriptional	NULL
activity	NULL
from	NULL
the	NULL
intact	NULL
AP	NULL
and	NULL
NAP	NULL
SIV	NULL
LTRs	NULL
.	NULL

These	NULL
studies	NULL
also	NULL
showed	NULL
that	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
NFB	NULL
binding	NULL
site	NULL
are	NULL
absolutely	NULL
required	NULL
for	NULL
enhancement	NULL
of	NULL
transcription	NULL
,	NULL
since	NULL
enhancement	NULL
was	NULL
abolished	NULL
upon	NULL
mutation	NULL
of	NULL
the	NULL
NFB	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
more-than-additive	NULL
transcriptional	NULL
effect	NULL
of	NULL
the	NULL
22-bp	NULL
enhancer	NULL
duplication	NULL
may	NULL
result	NULL
from	NULL
one	NULL
of	NULL
several	NULL
mechanisms	NULL
.	NULL

These	NULL
include	NULL
synergistic	NULL
interactions	NULL
between	NULL
bound	NULL
NFB	NULL
proteins	NULL
and	NULL
other	NULL
components	NULL
of	NULL
a	NULL
single	NULL
transcription	NULL
complex	NULL
,	NULL
including	NULL
other	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
SF3	NULL
(	NULL
67	NULL
)	NULL
or	NULL
Spil	NULL
(	NULL
52	NULL
,	NULL
61	NULL
)	NULL
,	NULL
which	NULL
is	NULL
present	NULL
both	NULL
in	NULL
the	NULL
SV40	NULL
promoter	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
and	NULL
in	NULL
the	NULL
native	NULL
SIV	NULL
LTR	NULL
.	NULL

Alternatively	NULL
,	NULL
there	NULL
may	NULL
be	NULL
kinetic	NULL
synergism	NULL
between	NULL
NFkB	NULL
complexes	NULL
bound	NULL
to	NULL
the	NULL
two	NULL
tandem	NULL
NFB	NULL
sites	NULL
(	NULL
29	NULL
)	NULL
or	NULL
cooperative	NULL
DNA	NULL
binding	NULL
by	NULL
some	NULL
NFB	NULL
proteins	NULL
(	NULL
52	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
interesting	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
constitutive	NULL
transcription	NULL
factor	NULL
SF3	NULL
alone	NULL
can	NULL
provide	NULL
a	NULL
considerable	NULL
level	NULL
of	NULL
transcriptional	NULL
enhancement	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
fivefold	NULL
greater	NULL
than	NULL
Neg	NULL
.	NULL

ctrl	NULL
.	NULL

D	NULL
Pos	NULL
.	NULL

ctrl	NULL
.	NULL

(	NULL
PMA	NULL
)	NULL
DEW	NULL
-1	NULL
DEW-2	NULL
DEW	NULL
-3	NULL
[	NULL
(	NULL
¥	NULL
)	NULL
00	NULL
20	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
-CG-	NULL
Proliferation	NULL
Index	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Induction	NULL
of	NULL
cellular	NULL
proliferation	NULL
by	NULL
recombinant	NULL
SIVs	NULL
.	NULL

Quiescent	NULL
pig-tailed	NULL
macaque	NULL
PBMC	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
without	NULL
PHA	NULL
or	NULL
IL-2	NULL
,	NULL
and	NULL
human	NULL
AB	NULL
serum	NULL
was	NULL
substituted	NULL
for	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
infected	NULL
with	NULL
recombinant	NULL
SIVs	NULL
,	NULL
and	NULL
cellular	NULL
proliferation	NULL
was	NULL
quantitated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
in	NULL
which	NULL
PBMC	NULL
from	NULL
two	NULL
different	NULL
macaques	NULL
were	NULL
used	NULL
;	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
mean	NULL
values	NULL
are	NULL
marked	NULL
by	NULL
bars	NULL
.	NULL

VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
background	NULL
levels	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
might	NULL
help	NULL
to	NULL
explain	NULL
why	NULL
derivatives	NULL
of	NULL
SIV	NULL
that	NULL
contained	NULL
a	NULL
mutated	NULL
NFB	NULL
LTR	NULL
but	NULL
an	NULL
intact	NULL
SF3	NULL
site	NULL
replicated	NULL
to	NULL
normal	NULL
levels	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
transcriptional	NULL
data	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
NFkB	NULL
plays	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
both	NULL
basal	NULL
and	NULL
cytokine/	NULL
mitogen-inducible	NULL
transcription	NULL
from	NULL
the	NULL
SIV	NULL
.inqmpy	NULL
;	NULL
14	NULL
LTR	NULL
.	NULL

Transient	NULL
transfection	NULL
analyses	NULL
do	NULL
not	NULL
,	NULL
however	NULL
,	NULL
always	NULL
reveal	NULL
the	NULL
effects	NULL
of	NULL
LTR	NULL
mutations	NULL
when	NULL
they	NULL
are	NULL
introduced	NULL
into	NULL
intact	NULL
clones	NULL
of	NULL
HIV-1	NULL
or	NULL
SIV	NULL
(	NULL
7	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Two	NULL
pairs	NULL
of	NULL
recombinant	NULL
SIVs	NULL
,	NULL
which	NULL
were	NULL
isogenic	NULL
except	NULL
for	NULL
LTR	NULL
elements	NULL
from	NULL
-172	NULL
to	NULL
+102	NULL
,	NULL
were	NULL
constructed	NULL
.	NULL

These	NULL
permitted	NULL
a	NULL
comparison	NULL
of	NULL
the	NULL
phenotypic	NULL
properties	NULL
conferred	NULL
on	NULL
intact	NULL
SIVs	NULL
by	NULL
the	NULL
same	NULL
five	NULL
LTR	NULL
point	NULL
mutations	NULL
and	NULL
22-bp	NULL
duplication	NULL
that	NULL
were	NULL
contained	NULL
in	NULL
our	NULL
LTR-luciferase	NULL
reporter	NULL
constructs	NULL
.	NULL

Molecular	NULL
clones	NULL
DEW-1	NULL
and	NULL
DEW-3	NULL
contain	NULL
AP	NULL
LTR	NULL
sequences	NULL
,	NULL
whereas	NULL
clones	NULL
DEW-2	NULL
and	NULL
DEW-4	NULL
contain	NULL
NAP	NULL
LTRs	NULL
.	NULL

These	NULL
LTRs	NULL
were	NULL
paired	NULL
with	NULL
different	NULL
3	NULL
'	NULL
genome	NULL
halves	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
env	NULL
and	NULL
accessory	NULL
genes	NULL
)	NULL
in	NULL
DEW-1	NULL
and	NULL
DEW-2	NULL
versus	NULL
DEW-3	NULL
and	NULL
DEW-4	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
biologic	NULL
properties	NULL
conferred	NULL
by	NULL
LTR	NULL
elements	NULL
were	NULL
influenced	NULL
by	NULL
other	NULL
SIV	NULL
genetic	NULL
determinants	NULL
.	NULL

Replication	NULL
studies	NULL
using	NULL
these	NULL
recombinant	NULL
SIVs	NULL
revealed	NULL
that	NULL
LTR	NULL
sequences	NULL
do	NULL
in	NULL
fact	NULL
influence	NULL
viral	NULL
replication	NULL
in	NULL
continuous	NULL
cell	NULL
lines	NULL
.	NULL

Inclusion	NULL
of	NULL
AP	NULL
LTR	NULL
sequences	NULL
in	NULL
otherwise	NULL
isogenic	NULL
SIVs	NULL
consistently	NULL
resulted	NULL
in	NULL
faster	NULL
kinetics	NULL
of	NULL
virus	NULL
replication	NULL
in	NULL
continuous	NULL
cell	NULL
lines	NULL
,	NULL
although	NULL
final	NULL
levels	NULL
of	NULL
virus	NULL
production	NULL
were	NULL
not	NULL
affected	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
the	NULL
ability	NULL
of	NULL
each	NULL
of	NULL
these	NULL
viruses	NULL
to	NULL
trigger	NULL
proliferation	NULL
of	NULL
resting	NULL
simian	NULL
PBMC	NULL
in	NULL
vitro	NULL
.	NULL

This	NULL
property	NULL
has	NULL
consistently	NULL
proved	NULL
to	NULL
be	NULL
the	NULL
most	NULL
reliable	NULL
in	NULL
vitro	NULL
correlate	NULL
of	NULL
acute	NULL
disease	NULL
induction	NULL
in	NULL
vivo	NULL
(	NULL
24	NULL
,	NULL
49	NULL
)	NULL
,	NULL
and	NULL
viral	NULL
genetic	NULL
determinants	NULL
in	NULL
both	NULL
gag	NULL
and	NULL
env	NULL
are	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
proliferation	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
confirmed	NULL
that	NULL
3	NULL
'	NULL
genome	NULL
half	NULL
sequences	NULL
(	NULL
presumably	NULL
env	NULL
)	NULL
are	NULL
indeed	NULL
crucial	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
cellular	NULL
proliferation	NULL
by	NULL
SIV	NULL
;	NULL
,	NULL
,	NULL
..pg	NULL
;	NULL
14	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
data	NULL
showed	NULL
that	NULL
SIVs	NULL
containing	NULL
AP	NULL
LTR	NULL
elements	NULL
were	NULL
significantly	NULL
(	NULL
two-	NULL
to	NULL
threefold	NULL
)	NULL
more	NULL
efficient	NULL
inducers	NULL
of	NULL
cellular	NULL
proliferation	NULL
compared	NULL
with	NULL
viruses	NULL
containing	NULL
NAP	NULL
LTR	NULL
elements	NULL
.	NULL

These	NULL
findings	NULL
demonstrate	NULL
that	NULL
LTR	NULL
elements	NULL
can	NULL
strongly	NULL
influence	NULL
a	NULL
crucial	NULL
biologic	NULL
property	NULL
of	NULL
SIV	NULL
smmpBj10	NULL
possibly	NULL
as	NULL
a	NULL
result	NULL
of	NULL
increasing	NULL
the	NULL
kinetics	NULL
of	NULL
virus	NULL
replication	NULL
during	NULL
the	NULL
initial	NULL
phase	NULL
of	NULL
infection	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
data	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
viral	NULL
determinants	NULL
of	NULL
pathogenesis	NULL
for	NULL
individual	NULL
strains	NULL
of	NULL
SIV	NULL
and	NULL
HIV-1	NULL
may	NULL
be	NULL
multifactorial	NULL
and	NULL
reflect	NULL
coevolution	NULL
at	NULL
multiple	NULL
genetic	NULL
loci	NULL
.	NULL

Thus	NULL
,	NULL
LTR	NULL
mutations	NULL
in	NULL
SIVgnmppii4	NULL
MY	NULL
reflect	NULL
an	NULL
adaptation	NULL
that	NULL
allows	NULL
the	NULL
virus	NULL
to	NULL
more	NULL
efficiently	NULL
exploit	NULL
cellular	NULL
responses	NULL
to	NULL
the	NULL
elevated	NULL
cytokine	NULL
levels	NULL
that	NULL
occur	NULL
during	NULL
acute	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
.	NULL

A	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
SIV	NULL
and	NULL
HIV-1	NULL
may	NULL
provide	NULL
important	NULL
insights	NULL
into	NULL
possible	NULL
strategies	NULL
to	NULL
control	NULL
viral	NULL
infection	NULL
and	NULL
disease	NULL
.	NULL

For	NULL
example	NULL
,	NULL
antioxi-dants	NULL
,	NULL
antitranscriptional	NULL
drugs	NULL
,	NULL
and	NULL
antagonists	NULL
of	NULL
NFkB	NULL
activation	NULL
might	NULL
prove	NULL
effective	NULL
in	NULL
limiting	NULL
the	NULL
initial	NULL
spread	NULL
of	NULL
HIV-1	NULL
as	NULL
well	NULL
as	NULL
the	NULL
reactivation	NULL
of	NULL
latent	NULL
proviruses	NULL
(	NULL
10	NULL
,	NULL
43	NULL
,	NULL
56	NULL
,	NULL
60	NULL
)	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
David	NULL
Markovitz	NULL
and	NULL
Frank	NULL
Novembre	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
to	NULL
Alanna	NULL
Ruddell	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
to	NULL
Daria	NULL
Krenitsky	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
,	NULL
to	NULL
Richard	NULL
Raubertas	NULL
for	NULL
advice	NULL
on	NULL
statistics	NULL
,	NULL
and	NULL
to	NULL
Becky	NULL
Schwiebert	NULL
for	NULL
obtaining	NULL
blood	NULL
samples	NULL
from	NULL
macaques	NULL
,	NULL
which	NULL
were	NULL
housed	NULL
at	NULL
the	NULL
University	NULL
of	NULL
Alabama	NULL
at	NULL
Birmingham	NULL
according	NULL
to	NULL
Animal	NULL
Welfare	NULL
Act	NULL
guidelines	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
the	NULL
following	NULL
for	NULL
generous	NULL
gifts	NULL
of	NULL
plasmids	NULL
or	NULL
cells	NULL
:	NULL
Gary	NULL
Nabel	NULL
(	NULL
NFB	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
vectors	NULL
)	NULL
,	NULL
CONTRIBUTION	NULL
OF	NULL
NFxB	NULL
TO	NULL
PHENOTYPE	NULL
OF	NULL
$	NULL
IVmmpmis	NULL
-	NULL
7807	NULL
Peter	NULL
Nara	NULL
(	NULL
ChM114	NULL
cells	NULL
)	NULL
,	NULL
Arnold	NULL
Rabson	NULL
(	NULL
SW480	NULL
cells	NULL
)	NULL
,	NULL
Neil	NULL
Perkins	NULL
(	NULL
Jurkat	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
Kanji	NULL
Miyamoto	NULL
(	NULL
Si-IIA	NULL
cells	NULL
)	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grants	NULL
to	NULL
S.D	NULL
.	NULL

(	NULL
RO1	NULL
AI31342	NULL
and	NULL
KO4	NULL
AI01240	NULL
)	NULL
and	NULL
to	NULL
S.C.D	NULL
.	NULL

(	NULL
F32	NULL
AIO8894	NULL
)	NULL
and	NULL
by	NULL
a	NULL
Howard	NULL
Hughes	NULL
Memorial	NULL
Institute	NULL
summer	NULL
research	NULL
fellowship	NULL
to	NULL
S.T	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aldovini	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Feinberg	NULL
.	NULL

1990	NULL
.	NULL

Transfection	NULL
of	NULL
molecularly	NULL
cloned	NULL
HIV	NULL
genomes	NULL
,	NULL
p.	NULL
147-175	NULL
.	NULL

In	NULL
A.	NULL
Aldovini	NULL
and	NULL
B.	NULL
D.	NULL
Walker	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Stockton	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

2	NULL
.	NULL

Anderson	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Clements	NULL
.	NULL

1991	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeats	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
viruses	NULL
SIV	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,251	NULL
and	NULL
SIV	NULL
,	NULL
,	NULL
,	NULL
,239	NULL
in	NULL
T-cell	NULL
lines	NULL
and	NULL
macrophage	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:51-60	NULL
.	NULL

3	NULL
.	NULL

Anderson	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Clements	NULL
.	NULL

1992	NULL
.	NULL

Two	NULL
strains	NULL
of	NULL
SIV	NULL
.	NULL

,	NULL
.	NULL

,	NULL
.	NULL

show	NULL
differential	NULL
transactivation	NULL
mediated	NULL
by	NULL
sequences	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

Virology	NULL
191:559-568	NULL
.	NULL

4	NULL
.	NULL

Aukrust	NULL
,	NULL
P.	NULL
,	NULL
N.~-B	NULL
.	NULL

Liabakk	NULL
,	NULL
F.	NULL
Muller	NULL
,	NULL
E.	NULL
Lien	NULL
,	NULL
T.	NULL
Espevik	NULL
,	NULL
and	NULL
S.	NULL
S.	NULL
Froland	NULL
.	NULL

1994	NULL
.	NULL

Serum	NULL
levels	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
soluble	NULL
TNF	NULL
receptors	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection-cortelations	NULL
to	NULL
clinical	NULL
,	NULL
immunologic	NULL
,	NULL
and	NULL
virologic	NULL
parameters	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

169:420-424	NULL
.	NULL

5	NULL
.	NULL

Barry	NULL
,	NULL
P.	NULL
,	NULL
E.	NULL
Pratt-Lowe	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Luciw	NULL
.	NULL

1989	NULL
.	NULL

Electroporation	NULL
of	NULL
T-cell	NULL
and	NULL
macrophage	NULL
cell	NULL
lines	NULL
.	NULL

Bio-Rad	NULL
bulletin	NULL
1349	NULL
.	NULL

Bio-Rad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
6	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Activation	NULL
of	NULL
multiple	NULL
NF-kB/Rel	NULL
DNA-binding	NULL
complexes	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Oncogene	NULL
9:1487-1492	NULL
.	NULL

7	NULL
.	NULL

Bellas	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
N.	NULL
Hopkins	NULL
,	NULL
and	NULL
Y.	NULL
Li	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
xB	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
efficient	NULL
replication	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
of	NULL
macaques	NULL
in	NULL
primary	NULL
macrophages	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2908-2913	NULL
.	NULL

8	NULL
.	NULL

Birx	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
G.	NULL
Lewis	NULL
,	NULL
M.	NULL
Vahey	NULL
,	NULL
K.	NULL
Tencer	NULL
,	NULL
P.	NULL
Zack	NULL
,	NULL
C.	NULL
R.	NULL
Brown	NULL
,	NULL
P.	NULL
B.	NULL
Jahrling	NULL
,	NULL
G.	NULL
Tosato	NULL
,	NULL
D.	NULL
Burke	NULL
,	NULL
and	NULL
R.	NULL
Redfield	NULL
.	NULL

1993	NULL
.	NULL

Association	NULL
of	NULL
interleukin-6	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acutely	NULL
fatal	NULL
SIV	NULL
anmpp	NULL
;	NULL
i4	NULL
in	NULL
pigtailed	NULL
macaques	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
9:1123-1129	NULL
.	NULL

9	NULL
.	NULL

Birx	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
R.	NULL
Redfield	NULL
,	NULL
K.	NULL
Tencer	NULL
,	NULL
A.	NULL
Fowler	NULL
,	NULL
D.	NULL
S.	NULL
Burke	NULL
,	NULL
and	NULL
G.	NULL
Tosato	NULL
.	NULL

1990	NULL
.	NULL

Abnormally	NULL
elevated	NULL
interleukin	NULL
6	NULL
levels	NULL
in	NULL
individuals	NULL
with	NULL
HIV	NULL
infection	NULL
.	NULL

Blood	NULL
76:2303-2310	NULL
.	NULL

10	NULL
.	NULL

Biswas	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
C.	NULL
M.	NULL
Ahlers	NULL
,	NULL
B.	NULL
J.	NULL
Dezube	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Pardee	NULL
.	NULL

1993	NULL
.	NULL

Cooperative	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
and	NULL
Tat-induced	NULL
superactivation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:11044-11048	NULL
.	NULL

11.	NULL
Cooper	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
P.	NULL
Maclean	NULL
,	NULL
R.	NULL
Finlayson	NULL
,	NULL
H.	NULL
M.	NULL
Michelmore	NULL
,	NULL
J	NULL
.	NULL

Gold	NULL
,	NULL
B.	NULL
Donovan	NULL
,	NULL
T.	NULL
G.	NULL
Barnes	NULL
,	NULL
P.	NULL
Brooke	NULL
,	NULL
and	NULL
R.	NULL
Penny	NULL
.	NULL

1985	NULL
.	NULL

Acute	NULL
AIDS	NULL
retrovirus	NULL
infection	NULL
.	NULL

Definition	NULL
of	NULL
a	NULL
clinical	NULL
illness	NULL
associated	NULL
with	NULL
seroconversion	NULL
.	NULL

Lancet	NULL
i:537-545	NULL
.	NULL

12	NULL
.	NULL

Courgnaud	NULL
,	NULL
V.	NULL
,	NULL
F.	NULL
Laure	NULL
,	NULL
P.	NULL
N.	NULL
Fultz	NULL
,	NULL
L	NULL
,	NULL
Montagnier	NULL
,	NULL
C.	NULL
Brechot	NULL
,	NULL
and	NULL
P.	NULL
Sonigo	NULL
.	NULL

1992	NULL
.	NULL

Genetic	NULL
differences	NULL
accounting	NULL
for	NULL
evolution	NULL
and	NULL
pathogenicity	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
from	NULL
a	NULL
sooty	NULL
mangabey	NULL
monkey	NULL
after	NULL
cross-species	NULL
transmission	NULL
to	NULL
a	NULL
pig-tailed	NULL
macaque	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:414-419	NULL
.	NULL

13	NULL
.	NULL

Chen	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
H.	NULL
Okayama	NULL
.	NULL

1987	NULL
.	NULL

High-efficiency	NULL
transformation	NULL
of	NULL
mammalian	NULL
cells	NULL
by	NULL
plasmid	NULL
DNA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:2745-2752	NULL
.	NULL

14	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
M.	NULL
S.	NULL
Saag	NULL
,	NULL
W.	NULL
D.	NULL
Decker	NULL
,	NULL
S.	NULL
Campbell-Hill	NULL
,	NULL
J.	NULL
L.	NULL
Roberson	NULL
,	NULL
P.	NULL
J.	NULL
Veldkamp	NULL
,	NULL
J.	NULL
C.	NULL
Kappes	NULL
,	NULL
B.	NULL
H.	NULL
Hahn	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Shaw	NULL
.	NULL

1991	NULL
.	NULL

High	NULL
titers	NULL
of	NULL
cytopathic	NULL
virus	NULL
in	NULL
plasma	NULL
of	NULL
patients	NULL
with	NULL
symptomatic	NULL
primary	NULL
HIV-1	NULL
infection	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

324:954-960	NULL
.	NULL

15	NULL
.	NULL

Daar	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
T.	NULL
Moudgil	NULL
,	NULL
R.	NULL
D.	NULL
Meyer	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Ho	NULL
.	NULL

1991	NULL
.	NULL

Transient	NULL
high	NULL
levels	NULL
of	NULL
viremia	NULL
in	NULL
patients	NULL
with	NULL
primary	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

324:961-964	NULL
.	NULL

16	NULL
.	NULL

Dewhurst	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
E.	NULL
Embretson	NULL
,	NULL
D.	NULL
C.	NULL
Anderson	NULL
,	NULL
J.	NULL
I.	NULL
Mullins	NULL
,	NULL
and	NULL
P.	NULL
N.	NULL
Fultz	NULL
.	NULL

1990	NULL
.	NULL

Sequence	NULL
analysis	NULL
and	NULL
acute	NULL
pathogenicity	NULL
of	NULL
molecularly	NULL
cloned	NULL
SIV	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
345:636-640	NULL
.	NULL

17	NULL
.	NULL

Dewhurst	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
E.	NULL
Embretson	NULL
,	NULL
P.	NULL
N.	NULL
Fultz	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Mullins	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
clones	NULL
from	NULL
a	NULL
non-acutely	NULL
pathogenic	NULL
derivative	NULL
of	NULL
SIV	NULL
mmppjis	NULL
:	NULL
Characterization	NULL
and	NULL
comparison	NULL
to	NULL
acutely	NULL
pathogenic	NULL
clones	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
8:1179-1187	NULL
.	NULL

18	NULL
.	NULL

Donahue	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
S.	NULL
L.	NULL
Quackenbush	NULL
,	NULL
M.	NULL
V.	NULL
Gallo	NULL
,	NULL
C.	NULL
M.	NULL
C.	NULL
7808	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

DOLLARD	NULL
ET	NULL
AL	NULL
.	NULL

deNoronha	NULL
,	NULL
J.	NULL
Overbaugh	NULL
,	NULL
E.	NULL
A.	NULL
Hoover	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Mullins	NULL
.	NULL

1991	NULL
.	NULL

Viral	NULL
genetic	NULL
determinants	NULL
of	NULL
T-cell	NULL
killing	NULL
and	NULL
immunodeficiency	NULL
disease	NULL
induction	NULL
by	NULL
the	NULL
feline	NULL
leukemia	NULL
virus	NULL
FeLV-FAIDS	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4461-4469	NULL
.	NULL

Doughtery	NULL
,	NULL
R.	NULL
M.	NULL
1964	NULL
.	NULL

Animal	NULL
virus	NULL
titration	NULL
techniques	NULL
,	NULL
p.	NULL
215-221	NULL
.	NULL

In	NULL
R.	NULL
J.	NULL
C.	NULL
Harris	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Techniques	NULL
in	NULL
experimental	NULL
virology	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Duh	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
W.	NULL
J.	NULL
Maury	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
activates	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
through	NULL
induction	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
NF-KB	NULL
sites	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:5974-5978	NULL
.	NULL

Embretson	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Zupancic	NULL
,	NULL
J.	NULL
L.	NULL
Ribas	NULL
,	NULL
A.	NULL
Burke	NULL
,	NULL
P.	NULL
Racz	NULL
,	NULL
K.	NULL
Tenner-Racz	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Haase	NULL
.	NULL

1993	NULL
.	NULL

Massive	NULL
covert	NULL
infection	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
and	NULL
macrophages	NULL
by	NULL
HIV	NULL
during	NULL
the	NULL
incubation	NULL
of	NULL
AIDS	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
362:359-362	NULL
.	NULL

Fried	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Crothers	NULL
.	NULL

1981	NULL
.	NULL

Equilibria	NULL
and	NULL
kinetics	NULL
of	NULL
lac	NULL
repressor-operator	NULL
interactions	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9:6505-6525	NULL
.	NULL

Fulton	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Plumb	NULL
,	NULL
R.	NULL
Shield	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Neil	NULL
.	NULL

1990	NULL
.	NULL

Structural	NULL
diversity	NULL
and	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeats	NULL
of	NULL
feline	NULL
leukemia	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1675-1682	NULL
.	NULL

Fultz	NULL
,	NULL
P.	NULL
N.	NULL
1991	NULL
.	NULL

Replication	NULL
of	NULL
an	NULL
acutely	NULL
lethal	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
activates	NULL
and	NULL
induces	NULL
proliferation	NULL
of	NULL
lympho-cytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4902-4909	NULL
.	NULL

Fultz	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
H.	NULL
M.	NULL
McClure	NULL
,	NULL
D.	NULL
C.	NULL
Anderson	NULL
,	NULL
and	NULL
W.	NULL
M.	NULL
Switzer	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
and	NULL
biologic	NULL
characterization	NULL
of	NULL
an	NULL
acutely	NULL
lethal	NULL
variant	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
from	NULL
sooty	NULL
manga-beys	NULL
(	NULL
SIV/SMM	NULL
)	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
5:397-409	NULL
.	NULL

Garner	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
Revzin	NULL
.	NULL

1981	NULL
.	NULL

A	NULL
gel	NULL
electrophoresis	NULL
method	NULL
for	NULL
quantifying	NULL
the	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
specific	NULL
DNA	NULL
regions	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9:3047-3060	NULL
.	NULL

Goff	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
P.	NULL
Tracktman	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1981	NULL
.	NULL

Isolation	NULL
and	NULL
properties	NULL
of	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
mutants	NULL
:	NULL
use	NULL
of	NULL
a	NULL
rapid	NULL
assay	NULL
for	NULL
release	NULL
of	NULL
virion	NULL
reverse	NULL
transcriptase	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

38:239-248.	NULL
.	NULL

Hannibal	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
N.	NULL
Clark	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
2	NULL
transcription	NULL
by	NULL
specific	NULL
T-cell	NULL
activation	NULL
signals	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5035-5040	NULL
.	NULL

Herschlag	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
F.	NULL
B.	NULL
Johnson	NULL
.	NULL

1993	NULL
.	NULL

Synergism	NULL
in	NULL
transcriptional	NULL
activation	NULL
:	NULL
a	NULL
kinetic	NULL
view	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:173-179	NULL
.	NULL

Higuchi	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Krummel	NULL
,	NULL
and	NULL
R.	NULL
K.	NULL
Saiki	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
general	NULL
method	NULL
of	NULL
in	NULL
vitro	NULL
preparation	NULL
and	NULL
specific	NULL
mutagenesis	NULL
of	NULL
DNA	NULL
frag-ments	NULL
:	NULL
study	NULL
of	NULL
protein	NULL
and	NULL
DNA	NULL
interactions	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16:7351-7367	NULL
.	NULL

Holland	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
C.	NULL
Y.	NULL
Thomas	NULL
,	NULL
S.	NULL
K.	NULL
Chattopadhyay	NULL
,	NULL
C.	NULL
Koehne	NULL
,	NULL
and	NULL
P.	NULL
V.	NULL
O'Donnell	NULL
.	NULL

1989	NULL
.	NULL

Influence	NULL
of	NULL
enhancer	NULL
sequences	NULL
on	NULL
thymotropism	NULL
and	NULL
leukemogenicity	NULL
of	NULL
mink	NULL
cell	NULL
focus-forming	NULL
viruses	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1284-1292	NULL
.	NULL

Israel	NULL
,	NULL
Z.	NULL
R.	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

Dean	NULL
,	NULL
D.	NULL
H.	NULL
Maul	NULL
,	NULL
S.	NULL
P.	NULL
O'Neil	NULL
,	NULL
M.	NULL
J.	NULL
Dreitz	NULL
,	NULL
J.	NULL
I.	NULL
Mullins	NULL
,	NULL
P.	NULL
N.	NULL
Fultz	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Hoover	NULL
.	NULL

1993	NULL
.	NULL

Early	NULL
pathogenesis	NULL
of	NULL
disease	NULL
caused	NULL
by	NULL
SIV	NULL
;	NULL
,	NULL
,	NULL
...	NULL
pg	NULL
;	NULL
i	NULL
,	NULL
molecular	NULL
clone	NULL
1.9	NULL
in	NULL
macaques	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
9:277-286	NULL
.	NULL

Kobayashi	NULL
,	NULL
S.	NULL
,	NULL
Y.	NULL
Hamamoto	NULL
,	NULL
N.	NULL
Kobayashi	NULL
,	NULL
and	NULL
N.	NULL
Yamamoto	NULL
.	NULL

1990	NULL
.	NULL

Serum	NULL
level	NULL
of	NULL
TNF-	NULL
«	NULL
in	NULL
HIV-infected	NULL
individuals	NULL
.	NULL

AIDS	NULL
4:169-170	NULL
.	NULL

Lang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
M.	NULL
Weeger	NULL
,	NULL
C.	NULL
Stahl-Hennig	NULL
,	NULL
C.	NULL
Coulibaly	NULL
,	NULL
G.	NULL
Hunsmann	NULL
,	NULL
J.	NULL
Muller	NULL
,	NULL
H.	NULL
Muller-Hermelink	NULL
,	NULL
D.	NULL
Fuchs	NULL
,	NULL
H.	NULL
Wachter	NULL
,	NULL
M.	NULL
M.	NULL
Danile	NULL
,	NULL
R.	NULL
C.	NULL
Desrosiers	NULL
,	NULL
and	NULL
B.	NULL
Fleckenstein	NULL
.	NULL

1993	NULL
.	NULL

Importance	NULL
of	NULL
vpr	NULL
for	NULL
infection	NULL
of	NULL
rhesus	NULL
monkeys	NULL
with	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:902-912	NULL
.	NULL

Lee	NULL
,	NULL
K.	NULL
A.	NULL
W.	NULL
,	NULL
A.	NULL
Bindereif	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
small	NULL
scale	NULL
procedure	NULL
for	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
that	NULL
support	NULL
efficient	NULL
transcription	NULL
and	NULL
pre-mRNA	NULL
splicing	NULL
.	NULL

Gene	NULL
Anal	NULL
.	NULL

Tech	NULL
.	NULL

5:22-31	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
ets-related	NULL
transcription	NULL
factor	NULL
,	NULL
Elf-1	NULL
,	NULL
binds	NULL
to	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
regulatory	NULL
elements	NULL
that	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
frans	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5890-5897	NULL
.	NULL

Lenz	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Celander	NULL
,	NULL
R.	NULL
L.	NULL
Crowther	NULL
,	NULL
R.	NULL
Patarca	NULL
,	NULL
D.	NULL
W.	NULL
Perkins	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1984	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
leukaemogenicity	NULL
of	NULL
a	NULL
murine	NULL
retrovirus	NULL
by	NULL
sequences	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

repeat	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
308:467-470	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Parrott	NULL
,	NULL
A.	NULL
J.	NULL
Buckler-White	NULL
,	NULL
W.	NULL
Turner	NULL
,	NULL
E.	NULL
K.	NULL
Ross	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
are	NULL
not	NULL
required	NULL
for	NULL
virus	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4919-4924	NULL
.	NULL

Letvin	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
and	NULL
N.	NULL
W.	NULL
King	NULL
.	NULL

1990	NULL
.	NULL

Immunologic	NULL
and	NULL
pathologic	NULL
manifestations	NULL
of	NULL
the	NULL
infection	NULL
of	NULL
rhesus	NULL
monkeys	NULL
with	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
of	NULL
macaques	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

3:1023-1040	NULL
.	NULL

Lewis	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
P.	NULL
M.	NULL
Zack	NULL
,	NULL
W.	NULL
R.	NULL
Elkins	NULL
,	NULL
and	NULL
P.	NULL
B.	NULL
Jahrling	NULL
.	NULL

1992	NULL
.	NULL

Infection	NULL
of	NULL
rhesus	NULL
and	NULL
cynomolgus	NULL
macaques	NULL
with	NULL
a	NULL
rapidly	NULL
fatal	NULL
SIV	NULL
(	NULL
SIVmaypp	NULL
;	NULL
)	NULL
isolate	NULL
from	NULL
sooty	NULL
mangabeys	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
8:1631-1639	NULL
.	NULL

Li	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
Golemis	NULL
,	NULL
J.	NULL
W.	NULL
Hartley	NULL
,	NULL
and	NULL
N.	NULL
Hopkins	NULL
.	NULL

1987	NULL
.	NULL

Disease	NULL
specificity	NULL
of	NULL
nondefective	NULL
Friend	NULL
and	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
viruses	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
small	NULL
number	NULL
of	NULL
nucleotides	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:693-700	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
xB-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
alpha-chain	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lympho-cytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2331-2335	NULL
.	NULL

Makonkawkeyoon	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
N.	NULL
R.	NULL
Limson-Pobre	NULL
,	NULL
A.	NULL
L	NULL
,	NULL
Moriera	NULL
,	NULL
V.	NULL
Schauf	NULL
,	NULL
and	NULL
G.	NULL
Kaplan	NULL
.	NULL

1993	NULL
.	NULL

Thalidomide	NULL
inhibits	NULL
the	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:5974-5978.	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
J.	NULL
Smith	NULL
,	NULL
J.	NULL
Hilfinger	NULL
,	NULL
M.	NULL
C.	NULL
Hannibal	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
is	NULL
dependent	NULL
on	NULL
purine	NULL
box	NULL
and	NULL
«	NULL
kB	NULL
regulatory	NULL
elements	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5479-5484	NULL
.	NULL

McClure	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
D.	NULL
C.	NULL
Anderson	NULL
,	NULL
P.	NULL
N.	NULL
Fultz	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Ansari	NULL
,	NULL
E.	NULL
Lockwood	NULL
,	NULL
and	NULL
A.	NULL
Brodie	NULL
.	NULL

1989	NULL
.	NULL

Spectrum	NULL
of	NULL
disease	NULL
in	NULL
macaque	NULL
monkeys	NULL
chronically	NULL
infected	NULL
with	NULL
SIV/SMM	NULL
.	NULL

Vet	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

21:13-24	NULL
.	NULL

Miyamoto	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Tomita	NULL
,	NULL
K.	NULL
Hayashi	NULL
,	NULL
and	NULL
T.	NULL
Akagi	NULL
.	NULL

1990	NULL
.	NULL

Transformation	NULL
of	NULL
animal	NULL
cells	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81:720-722	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nordeen	NULL
,	NULL
S.	NULL
K.	NULL
1988	NULL
.	NULL

Luciferase	NULL
reporter	NULL
gene	NULL
vectors	NULL
for	NULL
analysis	NULL
of	NULL
promoters	NULL
and	NULL
enhancers	NULL
.	NULL

BioTechniques	NULL
6:454-460	NULL
.	NULL

Novembre	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
P.	NULL
R.	NULL
Johnson	NULL
,	NULL
M.	NULL
G.	NULL
Lewis	NULL
,	NULL
D.	NULL
C.	NULL
Anderson	NULL
,	NULL
S.	NULL
Klumpp	NULL
,	NULL
H.	NULL
M.	NULL
McClure	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Hirsch	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
viral	NULL
determinants	NULL
contribute	NULL
to	NULL
pathogenicity	NULL
of	NULL
the	NULL
acutely	NULL
lethal	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
SIV	NULL
,	NULL
.napp	NULL
;	NULL
variant	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67	NULL
:	NULL
2466-2474	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Pantaleo	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
Grazioso	NULL
,	NULL
J.	NULL
F.	NULL
Demarest	NULL
,	NULL
L.	NULL
Butini	NULL
,	NULL
M.	NULL
Montronii	NULL
,	NULL
C.	NULL
H.	NULL
Fox	NULL
,	NULL
J.	NULL
Orenstein	NULL
,	NULL
D.	NULL
P.	NULL
Kotler	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

HIV	NULL
infection	NULL
is	NULL
active	NULL
and	NULL
progressive	NULL
in	NULL
lymphoid	NULL
tissue	NULL
during	NULL
the	NULL
clinically	NULL
latent	NULL
stage	NULL
of	NULL
disease	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
363:355-358	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
L.	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12	NULL
;	NULL
:3551-3558	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
W.	NULL
C.	NULL
Timmer	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Interleukin	NULL
6	NULL
induces	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
in	NULL
infected	NULL
monocytic	NULL
cells	NULL
alone	NULL
and	NULL
in	NULL
synergy	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
by	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:151-158	NULL
.	NULL

Reimann	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
K.	NULL
Tenner-Racz	NULL
,	NULL
P.	NULL
Racz	NULL
,	NULL
D.	NULL
C.	NULL
Montefiori	NULL
,	NULL
Y.	NULL
Yasutomi	NULL
,	NULL
W.	NULL
Lin	NULL
,	NULL
B.	NULL
J.	NULL
Ransil	NULL
,	NULL
and	NULL
N.	NULL
L.	NULL
Letvin	NULL
.	NULL

1994	NULL
.	NULL

Immuno-pathogenic	NULL
events	NULL
in	NULL
acute	NULL
infection	NULL
of	NULL
rhesus	NULL
monkeys	NULL
with	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
of	NULL
macaques	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:2362-2370	NULL
.	NULL

Renjifo	NULL
,	NULL
B.	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
S.	NULL
Winandy	NULL
,	NULL
N.	NULL
Hopkins	NULL
,	NULL
and	NULL
Y.	NULL
Li	NULL
.	NULL

1990.	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
U3	NULL
region	NULL
of	NULL
a	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3130-3134	NULL
.	NULL

VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
Staal	NULL
,	NULL
P.	NULL
A.	NULL
Raju	NULL
,	NULL
S.	NULL
W.	NULL
Ela	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
1990	NULL
.	NULL

Cytokine-stimulated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
is	NULL
inhibited	NULL
by	NULL
N-acetyl-L-cysteine	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4884-4888	NULL
.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Nicklen	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Coulson	NULL
.	NULL

1977	NULL
.	NULL

Sequencing	NULL
with	NULL
chain-terminating	NULL
inhibitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74:5463-5467	NULL
.	NULL
'	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
353:711-714	NULL
.	NULL
'	NULL

Schwiebert	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
N.	NULL
Fultz	NULL
.	NULL

1994	NULL
.	NULL

Immune	NULL
activation	NULL
and	NULL
viral	NULL
burden	NULL
in	NULL
acute	NULL
disease	NULL
induced	NULL
by	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
SIV	NULL
immppi14	NULL
:	NULL
correlation	NULL
between	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
events	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:5538-5547	NULL
.	NULL

’	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
M.	NULL
Roederer	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

Intracellular	NULL
thiols	NULL
regulate	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
kB	NULL
and	NULL
transcription	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9943-9947	NULL
.	NULL

Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

Transcriptional	NULL
activation	NULL
:	NULL
a	NULL
complex	NULL
puzzle	NULL
with	NULL
few	NULL
easy	NULL
pieces	NULL
.	NULL

Cell	NULL
77:5-8	NULL
.	NULL

Tsujimoto	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Komuro	NULL
,	NULL
K.	NULL
Iijima	NULL
,	NULL
J.	NULL
Miyamoto	NULL
,	NULL
K.	NULL
Ishikawa	NULL
,	NULL
CONTRIBUTION	NULL
OF	NULL
NFkB	NULL
TO	NULL
PHENOTYPE	NULL
OF	NULL
63	NULL
.	NULL

65	NULL
.	NULL

67	NULL
.	NULL

7809	NULL
and	NULL
M.	NULL
Hayami	NULL
.	NULL

1985	NULL
.	NULL

Isolation	NULL
of	NULL
simian	NULL
retroviruses	NULL
closely	NULL
related	NULL
to	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
by	NULL
establishment	NULL
of	NULL
lymphoid	NULL
cell	NULL
lines	NULL
from	NULL
various	NULL
non-human	NULL
primates	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
35:377-384.	NULL
van	NULL
den	NULL
Hoff	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
A.	NULL
F.	NULL
M.	NULL
Moorman	NULL
,	NULL
and	NULL
W.	NULL
H.	NULL
Lamers	NULL
.	NULL

1992	NULL
.	NULL

Electroporation	NULL
in	NULL
``	NULL
intracellular	NULL
``	NULL
buffer	NULL
increases	NULL
cell	NULL
sur-vival	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:2902.	NULL
.	NULL

Viglianti	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Mullins	NULL
.	NULL

1988	NULL
.	NULL

Functional	NULL
comparison	NULL
of	NULL
transactivation	NULL
by	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
from	NULL
rhesus	NULL
macaques	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:4523-4532	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
Wasylyk	NULL
,	NULL
P.	NULL
Flores	NULL
,	NULL
A.	NULL
Begue	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
c-ets	NULL
proto-oncogenes	NULL
encode	NULL
transcriptional	NULL
factors	NULL
that	NULL
cooperate	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:191-193.	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Flores	NULL
,	NULL
A.	NULL
Gutman	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1989	NULL
.	NULL

PEA3	NULL
is	NULL
a	NULL
nuclear	NULL
target	NULL
for	NULL
transcription	NULL
activation	NULL
by	NULL
non-nuclear	NULL
onco-genes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:3371-3378	NULL
.	NULL

Winandy	NULL
,	NULL
S.	NULL
,	NULL
B.	NULL
Renjifo	NULL
,	NULL
Y.	NULL
Li	NULL
,	NULL
and	NULL
N.	NULL
Hopkins	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factors	NULL
that	NULL
bind	NULL
two	NULL
regions	NULL
important	NULL
to	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5216-5223	NULL
.	NULL

